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Abstract 
Endothelial cells express constitutively a NADPH oxidase 2 (Nox2), which by generating 
reactive oxygen species (ROS) plays an important role in the regulation of endothelial. 
function. The Nox2 has at least 4 regulatory subunits and p47phox is one of the major 
regulatory subunits of this enzyme. The p47pho)( has multiple serines at its C-terminal end, 
and the serine phosphorylation is essential for Nox2 activation. TNFa is an inflammatory 
cytokine with divergent biological functions in different cell types. A previous study has 
shown that TNFa is a stimulator of Nox2 activation in endothelial cells. However, it still 
remains to be elucidated whether p47phox serine phosphorylation is involved in TNFa-
induced endothelial ROS production. Therefore, the aim of this Ph.D project is to 
investigate the role of p47phox serine phosphorylation in TNFa-induced NADPH oxidase 
activation and endothelial ROS production. 
Ten serines ofp47phox (S303, S304, S315, S320, S328, S345, S348, S359, S370 and S379) 
were replaced by alanines in p47phox cDNA plasmid (pcDNA3.1 vector), using in vitro site-
directed mutagenesis. Mutated p47phox constructs were confirmed by molecular sequencing. 
A mouse lymphoid endothelial cell line (SVEC4-1 0) was used for gene transfection and the 
ROS production by SVEC4-10 cells was examined by NADPH-dependent lucigenin-
chemiluminescence. Under the basal condition (without TNFa stimulation), SVEC4-10 
cells transfected with p47phox mutants showed no significant changes in ROS production. 
After acute TNFa (lOOU/ml, 30 minutes) stimulation, cells transfected with p47phox 
S303/304A, S315A, S328A, S345A, S370A or S379A plasmids showed a significant 
reduction in ROS production as compared to control cells transfected with vector only, 
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whereas p47phox S320A, S348A and S359A mutations had no significant effect on TNFa-
induced ROS production. 
TNFa-induced MAPK phosphorylation was also examined in these cells transfected with 
p47phOX mutants. Comparing to cells transfected with pcDNA3.l vector, cells transfected 
with p47PhOX S328A, S345A, S370A or S379A plasmids reduced the levels of TNFa-
induced ERK1I2 phosphorylation, whereas cells transfected with p47phox S320A, S348A or 
S359A plasmids showed no significant changes in TNFa-induced ERK1I2 activation. 
Interestingly, p47phox S303/304A mutation reduced NADPH-dependent ROS production 
but had no significant effect on acute TNFa-induced ERK1I2, p38 MAPK and JNK 
activation. This was further verified using primary endothelial cells of mouse and human 
origin (mouse coronary microvascular endothelial cells and human lung endothelial cells), 
COS7phox cells and coronary microvascular endothelial cells isolated from p47Phox knockout 
mice. 
In conclusion, p47phox phosphorylation at multiple serines, including S303/304, S315, S328, 
S345, S370 and S379, is essential in TNFa-induced NADPH oxidase activation. Among 
these serines, serines 303 and 304 playa key role in acute TNFa.-induced ROS production, 
but are not involved in TNFa.-induced MAPK activation in cultured endothelial cells. 
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Chapter 1: General Introduction 
1.1 Reactive Oxygen Species and Cardiovascular Diseases 
Cardiovascular diseases (CVO) are one of the leading causes of death in the world. In the 
report published by the World Health Organisation (WHO) in 2005, it was estimated that 
17.5 million people (30% of all global deaths, as shown in Figure 1.1) died from 
cardiovascular diseases, and the trend with CVD being the leading cause of death 
worldwide will continue In the future (WHO website: http://www.who.intl 
cardiovacular_dieases/en/). 
Figure 1.1: The global percentages of diseases leading to death in 2005 in 
the world. 
Data 
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Despite of the increasing effort made in basic and clinical research, patients still suffer from 
the side-effects by the current medical approach to CVD. Apart from the limitation of 
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biological and medical techniques, another barrier is the poor understanding of molecular 
pathogenesis of CVD. Recent 20 years has seen a dramatically increase in the research of 
CVD at molecular and cellular level. Accumulating and compelling experimental evidence 
indicates that a group of small oxygen-derived molecules, called reactive oxygen species 
(ROS)? play an important pathophysiological role in the development of CVD (Suvorava 
and Kojda, 2009; Valko et aI., 2007; Walia et aI., 2003; Wolin, 2009; Wong et aI., 1994). 
Figure 1.2: Biochemical reactions of ROS formation. 
NO OONO- +4---
r--~----..... OH' 
cr 
-----+. HOCl 
Myeloperoxidase 
ROS formation generally begins with one electron reduction of molecular oxygen, giving 
rise to a superoxide anion (02',). This highly reactive molecule either directly reacts with 
nitic oxide (NO) to form peroxynitrite (OONO-), or is rapidly dismutated by superoxide 
dismutase (SOD) to form a more stable molecule, hydrogen peroxide (H202). By catalase 
and glutathione peroxidase, hydrogen peroxide is converted into water, but it can also lead 
to the formation of other ROS derivatives such as hydroxyl radicals (OH') and 
hypochlorous acid (HOC)) (As shown in Figure 1.2, Hancock et aI., 2001). 
Excessive ROS released from activated phagocytic cells were initially identified as an 
important event in the host defence (Lambeth, 2004; Sheppard et aI., 2005). It has been 
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becoming clear that ROS are also generated in the cardiovascular system, including 
endothelial cells (Bayraktutan et aI., 2000), cardiac fibroblasts (Pagano et aI., 1998), 
cardiomyocytes (Bendall et aI., 2002) and vascular smooth muscle cells (Su et aI., 2001). 
Vascular cells constitutively generate ROS at a low level in resting conditions, but rapidly 
augment ROS production in response to a variety of stimuli such as growth factors, 
cytokines, G-protein coupled receptor agonists, metabolic factors and mechanical forces 
(Brandes and Kreuzer, 2005; Harrison et aI., 2003a). Vascular ROS playa vital role in 
cardiovascular functions. However, the persistent high level of ROS production is able to 
imbalance a redox state where pro-oxidants overwhelm antioxidant capacity, leading to 
pathophysiological processes and free radical-induced cell damage (Droge, 2002). This 
situation is recognised as oxidative stress, which has been implicated in the pathogenesis of 
many cardiovascular diseases such as atherosclerosis, hypertension, heart failure and 
cardiac hypertrophy (Bendall et aI., 2002; Griendling et aI., 2000; Paravicini and Touyz, 
2006; Soccio et aI., 2005; Takimoto and Kass, 2007). 
1.2 Physiological Roles of Reactive Oxygen Species in Endothelial Cells 
The endothelium, a single layer of cells lining the interior surface of blood vessels and the 
heart, which plays an influential role in cardiovascular homoeostasis, involving vascular 
permeability, myocardial function, blood fluidity and inflammatory responses(Cai and 
Harrison, 2000; Li and Shah, 2004). Depending on the level and type of those free radicals, 
ROS production may distinctively contribute to cell growth, hypertrophy, apoptosis, 
endothelial activation and inflammation through intracellular signaling pathways (Li and 
Shah, 2004; Ray and Shah, 2005). 
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1.2.1 Regulation of Vascular Tone 
Regulation of vascular tone is via the actions of locally produced agents (Vane et al., 1990) 
Endothelin is one of the major vasoconstrictors, which exerts its vasoconstrictive actions 
via type A endothelin receptors (Levin, 1995). Of the vasodilators, nitric oxide (NO) plays 
an important role in endothelium-dependent (NO-dependent) vasorelaxation (Cai and 
Harrison, 2000). As superoxide is capable of rapidly interacting with NO to produce 
peroxynitrite, endothelial cells are able to regulate vasoconstriction by reducing NO 
bioavailablity via generation of superoxide. On the other hand, superoxide can also be 
converted to hydrogen peroxide by SOD. By this way, decreased superoxide level 
attenuates NOI02-· interaction, which alternatively recovers the amount of NO for 
vasorelaxation (Munzel et al., 1999). Therefore local SOD activity may also play an 
important role in regulating the NOI02-' balance. 
1.2.2 Redox Signaling 
Transduction of ROS signalling is an important biological event in modulating 
posttranslational modification of specific amino acid residues on proteins, leading to its 
conformational change. This structural alteration can acutely change protein function. 
Tyrosine phosphatases are a group of enzymes which function as phosphate remover from 
phosphorylated tyrosine residues. The activated tyrosine phosphatase is therefore able to 
maintain tyrosine kinase in an inactivated structure. Once the cysteine residue of tyrosine 
phosphatase is oxidised by ROS, the inactivated tyrosine phosphatase, in return, leads to 
tyrosine kinase in an active form (Klatt and Lamas, 2000). Peroxynitrite is a reactive 
oxidant, which is capable of modulating tyrosine by nitration of tyrosine residues as well as 
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oxidation of phosphotyrosine phosphatases. By this way, peroxynitrite is involved in 
signalling pathways relying on tyrosine phosphorylation and dephosphorylation (Klotz et 
aI.,2002). 
1.2.3 ROS in Endothelial Activation and Inflammation 
Inflammation is defined as a biological response of vascularised tissues to harmful stimuli. 
It occurs at the microvasculature, which are the main sites of vascular leak and leukocyte 
extravasation. The inflammation initiates with recruitment and adhesion of leukocytes to 
vascular endothelial cells, followed by their subsequent emigration from the blood across 
the endothelium. In the process, specific membrane-associated proteins, known as adhesion 
molecules, are expressed in both endothelial cells and leukocytes (Godin et aI., 1993). 
Adhesion molecules have two functions: one is to provide a 'bridge link' between 
endothelial cells and leukocytes; the other is to alter the concentration of intracellular Ca2+, 
ROS production and induce cytoskeletal rearrangement. Among the adhesion molecules 
expressed in endothelial cells, intercellular adhesion molecule 1 (ICAM-l), vascular cell 
adhesion molecule 1 (VCAM-l), endothelial leukocyte adhesion molecule-l (ELAM-I or 
E-selectin), and P-selectin have been well studied in the past. ICAM-I is expressed at a 
very low level in normal endothelial cells, but upreguated by inflammatory stimuli such as 
lipopolysaccharide and cytokines (interleukin-l, TNFa, interferon-I) (Godin et aI., 1993). 
Endothelial VCAM-l is also upregulated by cytokines (interleukin-l, TNFa) (Pober and 
Cotran, 1990). In addition, the inflammation response induces a rapid membrane 
translocation of P-selectin in activated endothelial cells, whereas E-selectin is 
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transcriptionally upregulated and exhibits its function after 4-6 hours of activation (Godin 
et aI., 1993). 
ROS have been implicated in regulation of endothelial cell adhesion molecule expression 
induced by cytokines. TNFa, one of inflammatory cytokines, is capable of upregulating 
VCAM-I and chemoattractant protein-I (MCP-l) expression via a redox-sensitive 
mechanism involving nuclear factor keppa B (NF-,,:B), which is inhibited by antioxidant or 
the NADPH oxidase inhibitor apocynin (True et aI., 2000; Weber et aI., 1994). Another 
study has also demonstrated that TNFa-induced ICAM-I, VCAM-I, and E-selectin 
expressions were suppressed by cells overexpressing SOD, through NF-KB inhibition 
(Chen et aI., 2003b). In addition, it has been found that NADPH oxidase and xanthine 
oxidase play an essential role in TNFa-induced endothelial P-selectin expression (Fan et aI., 
2002). 
In endothelial cells, the upregulation of adhesion molecule expression can also be induced 
by hypercholesterolaemia, ischaemia-reperfusion, and the renin-angiotensin system. 
Angiotensin II has been shown to transcriptionally regulate VCAM-I, which involve 
NADPH oxidase and NF-KB activation (Pueyo et aI., 2000). Using p47phox-l-mouse model, 
hypercholesterolaemia-induced leukocyte-endothelium adhesion and leukocyte emigration 
were significantly attenuated due to the failure of ROS generation by NADPH oxidase 
(Stokes et aI., 2001). In addition, hypercholesterolaemia failed to induce an effective P-
selectin-dependent adhesion of platelets and leukocytes in the cerebral microcirculation of 
gp9Iphox-l- mice (Ishikawa et aI., 2004). In the stimulation of ischaemia-reperfusion, 
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xanthine oxidase-derived ROS are an essential mediator in regulation of endothelial 
permeability (Meneshian and Bulkley, 2002). 
1.2.4 Growth, Migration and Apoptosis in Endothelial Cells 
Angiogenesis is defined as formation of new blood vessels from existing vessels in the 
physiological process and functions in growth and development, as well as wound healing. 
During new vessel formation, endothelial cells proliferate, migrate, and reorganise into 
tubular network. 
Growth factors and cellular interactions with the extracellular matrix are required to 
maintain endothelial cell growth and survival. Recent studies have shown that intracellular 
ROS at a low level are involved in both angiogenesis and endothelial cell survival (Abid et 
aI., 2000; Ushio-Fukai et aI., 2002). In endothelial cells, cell proliferation and migration 
regulated by vascular endothelial growth factor (VEGF) is dependent on NADPH oxidase-
derived ROS (Abid et aI., 2000). This is supported by the study showing that VEGF-
induced endothelial cell proliferation and migration were attenuated when cells were 
transfected with dominant negative Rac 1 or antisense gp91 phox oligonucleotides (U shio-
Fukai et aI., 2002). In this study, they also showed that VEGF-induced angiogenesis was 
significantly attenuated in gp91 phox-I- mice. In addition, NADPH oxidase-derived ROS are 
also involved in angiotensin II, shear stress, or oxidised LDL-induced endothelial cell 
migration and/or proliferation (Gu et aI., 2003; Rueckschloss et aI., 2001). In addition, ROS 
production by both mitochondria and NADPH oxidase have been shown to involve in 
hypoxia-induced endothelial cell proliferation (Schafer et aI., 2003). 
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During angiogenesis, endothelial cell migration requires ROS-regulated reorganisation of 
the actin cytoskeleton. By wounding confluent endothelial monolayer, ROS were found to 
play an essential role in actin cytoskeleton reorganisation for endothelial migration and 
regeneration (Moldovan et aI., 2000). Rac 1 is one of regulatory NADPH oxidase subunits, 
and it has been shown to participate in shear stress-induced endothelial cell polarisation, 
which is an important step in migratory response (Wojciak-Stothard and Ridley, 2003). In 
addition, it has been reported that increased superoxide production by reoxygenation of 
hypoxic endothelial cells is required for translocation of actin filaments to the 
sub membranous network and cytoskeletal reorganisation. This phenomenon is essential to 
prime endothelial cells for angiogenesis (Crawford et aI., 1996). 
Apoptosis is known as programmed cell death, which may function as a counterbalancer 
against cell proliferation to induce vascular degeneration. An increase in intracellular ROS 
production is often observed in apoptoic processes. However, Rac I-dependent endothelial 
ROS generation has shown a protective role against TNFa.-induced apoptosis (Galle et aI., 
2001). On the other hand, the rise in NADPH oxidase-derived ROS production by oxidised 
LDL or high glucose induced a promoted endothelial cell apoptosis (Li et aI., 1999). Both 
discoveries suggest that superoxide generated from NADPH oxidase plays a dual role in 
regulating both endothelial survival and death. A significant increase in intracellular ROS 
has been observed in detached endothelial cells from the extracellular matrix. However, the 
regulatory mechanism of intracellular ROS during anoikis remains unclear. Nevertheless, 
hydrogen peroxide has been found to induce apoptosis via downstream activation of c-Jun 
N-terminal kinase (JNK), whereas VEGF-induced extracellular signal-regulated kinase 
(ERK) activation is involved in endothelial cell survival (Irani, 2000). Endothelial cell 
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apoptosis is also mediated by mitochondria-derived ROS (Cai et aI., 1998). In 
mitochondria-induced apoptosis, the release of cytochrome c into the cytoplasm leads to an 
increase in mitochondrial ROS production, which subsequently activates mitochondrial 
permeability transition. Interestingly, the increased superoxide generation due to deficiency 
of mitochondrial cytochrome c oxidase has revealed a potential link to endothelial 
senescence (Xin et aI., 2003). 
1.3 Reactive Oxygen Species and Endothelial Dysfunction 
Endothelial dysfunction has been implicated in the pathophysiology of several 
cardiovascular disorders including atherosclerosis, hypertension, diabetic vasculopathy, 
and heart failure (Bauersachs and Schafer, 2004; Cai and Harrison, 2000; MacCarthy et aI., 
2001; Potenza et aI., 2009; Victor et aI., 2009). Although many factors have been found to 
be capable of inducing endothelial abnormalities, their regulatory mechanisms are still 
poorly understood. In the past, the endothelium-derived NO has been well studied and the 
reduced NO bioavailability is considered to be one the major factor leading to endothelial 
dysfunction. In vasculature, the main biological function of NO is responsible for 
endothelium-dependent vasorelaxation, as well as inhibition of platelet and leukocyte 
adhesion (Harrison et aI., 2003a). The decline in NO bioavailability is therefore considered 
to be an early step in the pathogenesis ofCVD. The reduction of NO bioavailabilitymay be 
triggerd by reduced expression of eNOS, or deficiency of eNOS substrate (L-arginine) 
and/or cofactor (tetrahydrobiopterin), or increased inactivation of NO by superoxide. 
Among these factors, NO inactivation by superoxide is recognised as a fundamentally 
important underlying mechanism in most settings. It should be noted, however, that 
hydrogen peroxide, derived from dismuation of supoeroxide by SOD, increases eNOS 
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expression through transcriptional and posttranscriptional mechanisms (Drummond et aI., 
2000). 
Endothelial cells regulate and maintain ROS at a required level via pro-oxidative and anti-
oxidative system. However, increased and sustained high levels of ROS production lead to 
an imbalance of ROS regulation, which is recognised as oxidative stress. It has becoming 
clear that over-generated superoxide is able to directly interacts with NO to form 
peroxynitrite, which consequently induces degradation of tetrahydrobiopterin and leads to 
eNOS uncoupling (Landmesser et aI., 2003). In most setting of oxidative stress-related 
endothelial dysfunction, the increased superoxide generation is not only from the 
endothelium itself but also contributed to from other cell types in the vessel wall, such as 
vascular smooth muscle cells and adventitial fibroblasts. 
The contribution of endothelial ROS is from different enzymatic sources including 
mitochondria, xanthine oxidase, uncoupled nitric oxide synthases, cytochrome p450 and 
NADPH oxidase. Among these sources, NADPH oxidase has been demonstrated as the 
major ROS player in endothelial ROS production (Guzik et aI., 2000). 
1.4 Phagocytic NADPH Oxidase 
The reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is a 
multi protein enzyme complex. It was identified and characterised in poly-morphonuclear 
neutrophils (PMN), mainly from studies about chronic granulomatous disease (CGD) , an 
illness of human genetic defects in essential NADPH oxidase components (Dinauer et aI., 
1990; Lomax et aI., 1989; Nunoi et aI., 1988; Volpp et aI., 1988; Volpp et aI., 1989). 
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Phagocytes playa crucial role in the host defence against invading pathogens (Babior et aI., 
2002; Janeway and Medzhitov, 2002). In response to acute infection, resting neutrophils are 
stimulated and produce superoxide anions by transferring electrons from NADPH to 
molecular oxygen in presence of NADPH oxidase. This highly reactive free radical can 
subsequently be converted to other reactive oxygen species which play crucial roles during 
phagocytosis (Pagano et aI., 1998; Segal et aI., 1992). 
The phagocyte NADPH oxidase (Ph ox) is composed of oxidase-specific proteins: 
cytochrome bss8, p47
phOX
, p67PhOX, p40PhOX, and the small guanosine triphosphate hydrolase 
(GTPase) Rac (Babior, 1999; Lambeth, 2002). The cytochrome bss8 is a membrane-bound 
flavohemoprotein , which functions to transfer electrons provided by cytosolic NADPH to 
molecular oxygen. It has been evident that the cytochrome bss8 is composed of a 
heterodimer of a 91-kDa glycoprotein and a 22-kDa nonglycosylated protein, known as 
gp91 phox and p22PhOX respectively , a flavin adenine dinucleotide, and two heme groups 
(Babior, 1999; Rotrosen et aI. , 1992). 
Figure 1.3: phagocyte-type NADPH oxidase 
Activated 
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Table 1.1: Comp"arison of human and other mammalian sequences of 
subunits of phagocytic NADPH oxidase. 
Human p22PhOX p40PhoX p47PhoX p67phox Nox2 
Bovine 86.9 89.1 84.7 87.9 91.6 
Bison 85.7 89.4 84.2 88.1 91.8 
Pig 81.6 92.2 
Rabbit 81.5 89.7 83.6 77.6 91.4 
Rat 88.8 
Mouse 86.7 85.3 82.4 83.8 92.8 
Dolphin 83.6 86.9 82.9 88.1 91.4 
Average 85 88.1 83.6 85.1 91.9 
Data are shown as identity of percentage between human protein sequences and those of 
other species (Adapted from Kawahara et at, 2007). 
In resting phaogyctes, NADPH oxidase exists as an unassembled form, where four 
regulatory NADPH oxidase subunits (and Rac) are present in the cytosol. In response to 
inflammatory stimulation, the activation of NADPH oxidase initiates with a rapid 
pshosphorylation of p47phox, p67ph0X, and p40Ph0X, and their subsequent specific 
conformational changes. In association with Rac, these cytosolic proteins translocate to the 
plasma membrane and target around the membrane-linked cytochrome bss8 to form an 
enzyme complex. This assembly is an essential prerequisite for enzyme activity. In the 
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presence ofNADPH, superoxide anion is formed by passing one electron through NADPH 
oxidase to molecular oxygen (Ambruso et aI., 1990; Clark et aI., 1990; el Benna et aI., 1994; 
Gabig et aI., 1995). It has been demonstrated that the NADPH oxidase subunits are highly 
conserved across mammalian species, indicating their essential role in immune reaction (As 
shown in Table 1.1). 
1.4.1 Nox2 
The Nox2 protein (570 amino acid residues), with a molecular weight of 65-kDa, is a key 
catalytic subunit of the NADPH oxidase. It can be seen as a 91-kDa band by sodium 
dodecyl sulphate (SDS) polyacrylamide gel electrophoresis due to is its posttranslational 
glycosylation. Therefore, Nox2 is also known as gp91 phox• This glycosylated membrane-
spanning protein contains six hydrophobic N-terminal domains, among which the third and 
fifth a-helices respectively possess two histidine residues that are able to coordinate two 
hemes. One heme is oriented towards the cytoplasmic face and the other one is oriented 
towards the outer face (Finegold et aI., 1996; Takeya et aI., 2003). The C-terminal half of 
Nox2 is a cytoplasmic domain homologous to ferredoxin-NADP+ reductase, bearing the 
NADPH-binding and flavin adenine dinucleotide (F AD)-binding sites (Segal et aI., 1992; 
Takeya et aI., 2003). As a result of perpendicular orientation of hemes to the membrane 
surface, electrons are transferred from cytosolic NADPH to molecular oxygen through 
FAD, and across the membrane via the hemes (Cross et aI., 1995). Therefore, the N-
terminal bis-heme-containing region ofNox2 is considered to playa vital role in facilitating 
transmembrane electron transport. 
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1.4.2 p22phOX 
The non-glycosylated NADPH oxidase subunit, p22phox (195 amino acid residues), is 
another membrane-integrated protein, existing in the form of specific interaction with Nox2 
in a 1: 1 ratio (Huang et aI., 1995). Although p22phox seems not to be directly associated 
with electron transfer, it preferentially functions by creating a stable cytochrome b558 
complex. This concept is supported by the discovery that Nox2-deficient CaD patients do 
not have detectable p22phox protein, and p22phox-deficient caD patients do not have 
detectable Nox2 protein (Parkos et aI., 1989). Another role of p22phox is to facilitate 
assembly of cytosolic NADPH oxidase subunits. The Study on p22Phox have revealed a 
proline-rich region (PRR) locating at its C-terminal cytoplasmic tail, and its specific 
interaction with Src Homology 3 (SH3) domain in p47phox has been shown to provide an 
anchoring site for the phosphorylated p47phox (Leto et aI., 1994). The cytosolic binding of 
p47phOX and p22PhOX activates the heme incorporation into gp65, the precursor of gp91 phox. It 
subsequently up-regulates glycosylation of gp65 to gp91 ph0x, which is crucial for formation 
of the active oxidase (DeLeo and Quinn, 1996). 
1.4.3 p47PhOX 
The p47PhOX protein is a highly basic protein with a length of 390 amino acid residues. It has 
four distinctive domains: an N-terminus phox homology (PX) domain, two Src homology 3 
(SH3) domains, an auto-inhibitory region (AIR) and a C-terminal proline-rich region (PRR) 
(Ago et aI., 2003; Finan et aI., 1994; Yuzawa et aI., 2004). Analysis of these functional 
domains have revealed that N-terminal PX domain is able to target p47phox to the plasma 
membrane by interacting with phosphoinositides (such as phosphatidylinositoI 3, 4-
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bisphosphate), phosphatidic acid or phosphatidylserine (Nakamura et aI., 1998), whereas its 
C-terminal proline-rich region provides a site which p67phOX binds to via its SH3 domain 
(Takeya et aI., 2003). The tandem SH3 domains of p47phoX, originally masked by the auto-
inhibitory domain in resting stage, are exposed during NADPH oxidase activation and 
interact with the C-terminal proline-rich region of p22phox (Ago et aI., 2003). This 
conformational change of p47phox is regulated by the phosphorylation status of mUltiple 
serine residues located in the autoinhibitory and proline-rich domains (el Benna et aI., 
1994). 
1.4.4 p67phOI 
The p67phOX, a regulatory protein with 526 amino acids, contains five distinctive domains: 
An N-terminal tetratricopeptide repeat motifs (TPRs), two SH3 domains, , an activation 
domain, an internal proline-rich domain and a Phox and Bern 1 (PB I) domain (Nakamura 
et aI., 1998; Ponting, 1996; Takeya et aI., 2003). The TPR motifs are the only domain 
among the cytosolic regulatory proteins, which has a specific binding region for Rac 
(Ponting, 1996). The activation domain associates with Nox2 following phosphorylation 
and translocation (Takeya et aI., 2003). The presence of the C-terminal SH3 and PB 1 
domains provides two sites for p47PhOX and p40Phox binding, although the function of the 
other SH3 domain remains unclear (Nakamura et aI., 1998; Uhlinger et at, 1994). 
1.4.5 p40PhOI 
The last identified NADPH oxidase subunit, p40PhoX, is composed of 339 amino acids with 
three functional domains: an N-terminal PX domain, an SH3 domain and a PB I domain 
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(Nakamura et aI., 1998; Wishart et aI., 2001). The p40Phox PX domain contains 120 amino 
acids, showing a similarity of spatial structure of the PX domain in p47phox• However, the 
PX domain of p40Phox specifically binds phosphatidylinositol 3-phosphate, whereas that of 
p47phox has two lipid binding sites (Stahelin et aI., 2003). The SH3 domain in p40Phox 
possesses an 30% of homologuous to the SH3 domains of p47phox and p67phoX, and its 
function is still controversial (Wientjes et aI., 1993). In addition, the p40Phox contains a PB 1 
domain at the C-terminal end, which provide a binding site for p67phox via PB I-PB I 
domain interaction (Wilson et aI., 2003). 
1.4.6 Rac1l2 
The cytosolic guanosine triphosphate (GTP)-binding protein, Rac, is a member of the Ras 
superfamily. Two isoforms of Rac1/2 are involved in NADPH oxidase acitivation (Abo et 
aI., 1991; Knaus et aI., 1991). Although Rac 1 contains more polybasic amino acid residues 
than Rac2, both of them have the similar binding affinities to p67phox_TPR domain (Diebold 
and Bokoch, 2001; Dusi et aI., 1996). The previous study has demonstrated that Rac has a 
dual role in the assembly ofNADPH oxidase. One is to tether p67Phox to the membrane; the 
other is to induce an activating conformational change in p67phox (Sarfstein et aI., 2004). 
1.4.7 Intramolecular and Intermolecular Interactions among NADPH Oxidase 
Subunits 
As a multi-subunit enzyme complex, the activity of NADPH oxidase is regulated by 
specific binding between its membrane-integrated catalytic centre and assembled cytosolic 
components. 
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In p47phOX, the N-terminal and C-terminal SH3 domains are masked by its own 
autoinhibitory region (AIR) in thre resting state. This intramoleuclar SH3-AIR interaction 
maintains the whole p47phOX peptides in a folded and closed conformation, which 
subsequently facilitate to another intramolecular association between PX domain and C-
terminal SH3 domain (Ago et aI. , 2003 ; Leto et aI., 1994; Sumimoto et aI. , 1994). When 
p47phOX is activated, multiple phosphorylation events occur in its C-terminus polybasic 
region, where the intramoleuclar SH3-AIR association is disrupted by the addition of 
negatively charged phosphate. The disrupted SH3-AIR interaction subsequently releases 
both SH3 and PX domains. The former binds to the C-terminal proline-rich region of 
p22PhOX (de Mendez et aI. , 1997; Huang and Kleinberg, 1999), whereas the later binds to 
membrane phosphoinositides (Ago et aI., 2003). Additionally, another intermolecular 
interaction occurs via a tail to tail formation between p47phox C-terminal poline-rich region 
and p67phOX C-terminal SH3 domain (Takeya et aI. , 2003). 
Figure 1.4: intermolecular interactions among NADPH oxidase subunits. 
c( '~'~'EP 
1 
p47PhO> (closed) I Multiple serine sites 
The graph is Modified from Ueyama et aI. , 2007. 
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The p67phOX contains a catalytic NADPH binding site for electron transfer to the FAD in the 
cytochrome bss8 complex, indicating its essential role in NADPH oxidase activation (Smith 
et aI., 1996). The p67phox interact with p40Phox via their PB I-PB 1 domain binding. This 
interaction is maintained as a constitutive association in resting and activated cells 
(Nakamura et aI., 1998). Although p67Phox is a crucial NADPH oxidase subunit, the 
activation of NADPH oxidase requires at least two factors. In addition to the interaction 
with phosphorylated p47phO", the involement of Rac protein is also necessary. Upon 
activation, phosphorylated p47phOX interacts with p67phox and translocates it to the 
cytochrome bss8 (Takeya et aI., 2003). Rac is disrupted from its inhibitory protein RhoGDI 
in the cytoplasm and recruited to the membrane, where Rac is converted to the GTP-bound 
active form. The activated Rac then interacts with p67phox N-terminal TPR domain, which 
subsequently facilitates the binding of the p67phox activation domain to Nox2 (Bokoch, 
2005; Dinauer, 2003). 
It has been reported that the p40PhOX is not essential for oxidase activation (Cross et at., 
1999). However, this protein enhances recruitment of p67phox and p47PhOX to the membrane, 
especially to the phagosomal membrane (Elison et aI., 2006; Kuribayashi et aI., 2002; Suh 
et aI., 2006). In phagoytes, the p40Phox forms a stable complex with p67Phox via a tail to tail 
association of PB 1 domains from their C-terminal ends (Nod a et aI., 2003). The p40Phox N-
terminal PX domain is capable of specificially and strongly binding to phosphatidylinositol 
3-phosphate, which is enriched in the phagosomal membrane (Kanai et at., 2001). This PX 
domain is therefore thought to mediate translocation ofp40Phox to phagosome. However, the 
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phosphatidylinositol 3-phosphate-binding activity is normally suppressed via an 
intramoleuclar interaction between p40Phox PX domain and PB 1 domain (Honbou et aI., 
2007). In contrast to p4 7phox and p67Phox SH3 domains, the role of p40Phox SH3 domain is 
still poorly understood, although it is capable of weakly binding to p47phox. 
Rac plays an essential role in NADPH oxidase activation. In contrast to p40PhoX, p47phox and 
p67phOX, Rac can independently translocate to membrane and bind to both the p67phox N-
terminal TPR motifs and flavocytochrome bss8 when phagocytes are stimulated. The 
sequential mechanism of Rae-binding interactions upon NADPH oxidase activation was 
elucidated by Diebold and Bokoch, who demonstrated that the Rac_p67phox interaction 
occurs preceded by Rac-flavocytochrome bss8 interaction. They also proposed that these 
two distinct Rac-dependent steps are related to the electron transfer process. Upon 
stimulation, Rac translocates to membrane-bound flavocytochrome bss8 and initiates 
electron flow from NADPH to FAD. Then it binds and modulates the translocated p67phoX, 
inducing a conformational change in p67phoX, which allows electron to flow from FAD to 
the hemes. 
1.5 Phosphorylation regulation of NADPH Oxidase 
1.5.1 Phosphorylation of p47phOl 
In activating NADPH oxidase system, phosphorylation is recognised to be an important 
step to up-regulate the assembly of cytosolic components of NADPH oxidase. The early 
phosphorylation analysis showed that p47phox is phosphorylated in the C-terminal portion of 
protein (residues 296-383) obtained after cyanogen bromide cleavage (EI Benna et aI., 
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1994). To identify the functions of phosphorylation at potential individual sites in p47phoX, a 
number of serines locating between S303 and S379 within the C-terminal region were 
investigated by EI Benna et al (EI Benna et aI., 1996a). In their study, eleven serine residues 
(S303, S304, S310, S315, S320, S328, S345, S348, S359, S370 and S379) were 
investigated in 32Pi-Ioaded human B lymphoblasts activated by phorbol myristate acetate 
(PMA), the protein kinase C (PKC) activator. By two-dimensional tryptic phosphopeptide 
mapping, peptides containing S303/304, S315, S320, S328, S345/348, S359/370, and 
S379/381 were shown to be phosphorylated, except the peptide containing S310. 
Nevertheless, further research revealed that the pattern of serine phosphorylation differs 
when phosphorylation of p47phox is induced by distinctive protein kinases (EI Benna et aI., 
1996a). By in vitro phosphorylation ofp47PhoX, it was found that PKC can phosphorylate all 
the serines mentioned above except the peptide containing S345/S348. In addition, it was 
suggested that protein kinase A can phosphorylate the peptide containing S320, S328 and 
S359/370, while the peptide with S345/S348 was only extensively phosphorylated by 
mitogen-activated protein kinase (MAPK) (EI Benna et aI., 1996a). Another study further 
identified that extracellular regulated kinase 112 (ERK1I2) and p38 MAPK but not c-Jun N-
terminal kinase (JNK) activate the specific S345 phosphorylation in p47phox (EI Benna et aI., 
1996b). Collectively, these findings suggest that different protein kinases play distinctive 
roles in activation of NADPH oxidase via selective phosphorylation of multiple serines at 
the C-terminal end ofp47phox• 
The role of individual p47PhOX serine phosphorylation (S303, S304, S31O, S315, S320, S328, 
S345, S348, S359, S370 and S379) was investigated by site-directed mutagenesis. In the 
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study, human p47phox-deficent B lymphoblasts transfected with all single serine to alanine 
mutations did not show an essential defect in PMA-induced NADPH oxidase activation, 
except the p47phOX S379 mutation (Faust et aI., 1995). However, the apparent decrease of 
activation of NADPH oxidase was observed when both S303 and S304 were converted to 
alanine, and it could be partially restored by transfecting p47phox-deficient B lymphoblast 
cells with p47phOX S303E/S304E, where the glutamate residues mimiC serine 
phosphorylation. Interestingly, by introducing S303K1304K mutation, in which both 
residues 303 and 304 carry positive rather than negative charges, the results showed normal 
p47phOX membrane translocation as well as NADPH oxidase activity (lnanami et aI., 1998). 
Subsequently, another study showed that triple substitutions of S303, S304 and S328 with 
aspartates could elicit an active conformation and even be capable of activating the 
NADPH oxidase without in vitro activators in cell-free conditions, but p47phox mutants with 
either S303D/S304D or S328D appeared inactive (Ago et aI., 1999). It can be concluded 
that phosphorylation of S303, S304 and S328 are required for disruption of the SH3-
mediated intermolecular interaction. 
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The p47phox S345 has been shown as a phosphoserine targeted by ERK1I2 and p38 MAPK-
induced (El Benna et aI., 1996b). A recent study has revealed that p47phox S345 
phosphorylation plays an essential role in priming neutrophil NADPH oxidase activation 
(Dang et aI., 2006). When neutrophils are exposed to Granulocyte/Macrophage-Colony 
Stimulating Factor (GM-CSF), Tumor necrosis factor alpha (TN Fa), or Interleukin 8 (IL-8), 
NADPH oxidase is able to increase but at a moderate level of superoxide production. The 
level ofROS is further elevated when neutrophils are stimulated with fMLP. In their report, 
they showed that p47PhOX S345 is phosphorylated by GM-CSF-induced ERK1I2 and TNFa-
induced p38 MAPK pathways. As a specific phosphorylated site, S345 is found only to be 
moderately phosphorylated in neutrophils with stimulation of fMLP or PMA, indicating 
that phosphorylation in at this site is selectively induced by priming conditions. In addition, 
mutation of S345 to alanine elicited a moderate defect in PMA-induced superoxide 
production. Therefore, the phosphorylation of p47phox S345 is thought to play an important 
role in facilitating a secondary phosphorylation of other serines and subsequent 
conformational change of p4 7phox• 
The roles of phosphorylation on S359 and S370 were demonstrated by Johnson et al 
(Johnson et aI., 1998). They showed that phosphorylation of these two serines could 
facilitate subsequent phosphorylation of remaining serines in p47phox• In their study, the 
dramatic reduction of PMA-induced NADPH oxidase activity was detected in p47phox_ 
deficient B lymphoblasts expressing the S359A1S370A or S359K1S370K double mutant, 
due to that these mutant proteins could not translocate to the plasma membrane following 
stimulation. Conversely, phosphorylation and translocation of p47phox with substitution of 
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S359 orland S370 with aspartate or glutamate was normal, although the enzyme activity 
was still reduced. These observations suggest that negative charge at position 359 orland 
370 is essential for facilitating phosphoryation of other serines and translocation of p47phox• 
The single serine to alanine mutation on p47phox S379 has been shown capable of inhibiting 
p47phox membrane translocation as well as NADPH oxidase activity, although abolishment 
of this phosphorylation site has no no effect on other serine phosphorylations (EI Benna et 
aI., 1994; Faust et aI., 1995). In this regard, phosphorylation upon p47phox S379 is proposed 
to possess a capacity of destabilising interactions between proline-rich region of p47phox and 
SH3 domains of p40PhOX and p67phox (Massenet et aI., 2005). 
Although the majority of studies have shown that p47phox serine phosphorylation is a major 
process in regulation ofNADPH oxidase activation, there is one report stating that p47phox 
is capable of undergoing tyrosine phosphorylation in Src-mediated signalling (Chowdhury 
et aI., 2005). However, the regulatory mechanism of this tyrosine phosphorylation remains 
unclear. 
1.5.2 Phosphorylation of Other Regulatory NADPH Oxidase Subunits 
In addition to p47phoX, two other cytoslic subunits, p40Phox and p67phox also undergo 
phosphorylation when neutrophil NADPH oxidase is stimulated. However, not much is 
known about regulation phosphorylation of p40Phox and p67phox• Phosphorylation of p67phox 
in the neutrophil occurs in the cytosol and is independent of p47phox phosphorylation 
(Forbes et aI., 1999a). The p67phox phosphorylation increases neutrophil NADPH oxidase 
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activity upon PMA stimulation, and it was demonstrated by Forbes et al that mutation of 
T233 to alanine resulted in a reduction phosphorylation in in vitro experiment (Forbes et aI., 
1999b). 
Phosphorylation of p40Phox was detected on multiple sites upon stimulation of neutrophil 
NADPH oxidase by PMA (Someya et aI., 1999). Through phosphoamino acid and tryptic 
peptide maps of phosphorylated p40Phox, phosphorylation ofp40phox T154 and S315 were 
observed upon activation of NADPH oxidase, and the former was found to play an 
inhibitory fact in regulation of p40PhOX conformational change (Bouin et at, 1998; Lopes et 
aI.,2004). 
In recent studies, phosphorylation of Nox2 and p22phox has been also detected during 
neutrophil NADPH oxidase activation. In neutrophil NADPH oxidase activation, Nox2 is 
phosphorylated via a PKC-dependent pathway. By two-dimensional tryptic peptide 
mapping analysis, it showed that PKC phosphorylated the Nox2-cytosolic tail, 
demonstrating that Nox2 phosphorylation by PKC enhances its catalytic activity and 
assembly of complex (Raad et aI., 2009). The p22phox phosphorylation is also essential for 
NADPH oxidase activation. Lewis et al. have recently identified a p22phox phosphorylation 
site at p22PhOX Thr147. Abolishment of this p22phox phosphorylation sites showed a reduced 
p22PhOX_p47PhOX binding affinity and subsequent NADPH oxidase-derived ROS production, 
indicating that phosphorylation of p22phOX facilitates p47phox membrane translocation (Lewis 
et al.). 
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1.6 Homology of NADPH Oxidase 
With the report that a superoxide-producing enzyme was found similar to the phagocyte 
NADPH oxidase in vascular smooth muscle cells (Lambeth et aI., 2000), other homologues 
ofNox2 were subsequently discovered in many nonphagocytic cells and designated as Nox 
family. To date, seven Nox members have been revealed, including Nox I, Nox2 (gp91 phox), 
Nox3, Nox4, Nox5, Duoxl and Duox2 (Bedard and Krause, 2007; Kawahara et aI., 2007; 
Nauseef, 2008), and the differentiation of Nox family expression can be seen in Table 1.2 
(Harrison et aI., 2003a). 
Table 1.2: Nox homologues in mammalian cells and tissues. 
Terminology Alternative Tissue Expressed Sequence Similarity 
Name to gp91 phox 
Noxi Moxi Colon, Uterus, Prostate, 56% 
VSMC 
Nox2 gp91 PhOX HL-60 cells, monocytes 
Nox3 Fetal tissues 58% 
Nox4 Renox Kidney, placenta, 39% 
glioblastoma cells 
Nox5 Fetal tissues, spleen, testis 27% 
Duoxl ThOXI Thyroid 53% 
Duox2 ThOX2 Thyroid 47% 
In addition, the investigation on Nox 1 has also elicited the discovery of homologues of 
p47phoxand p67phOX, designated as NoxOI and NoxAl respectively. Those two homologues 
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are primarily expressed in colon but also widely found in other tissues such as liver, 
pancreas, thymus and small intestines. NoxO I is a 41 kDa protein, displaying 23% amino 
acid sequence identity of p47phOX, but its structure appears similar to p47Phox and contains all 
the functional domains except the autoinhibitory domain. Like NoxOl, NoxAl exhibits 
28% amino aicd sequence identity with p67phox• Although this 51 kDa protein lacks of N-
terminal SH3 domain, it contains the rest of analogous functional domains in p67phox (Banfi 
et aI., 2003; Geiszt et aI., 2003; Takeya et aI., 2003). 
1.7 Characteristic of NADPH Oxidase Expressed in Endothelial Cells 
1.7.1 Endotheial NADPH Oxidase 
Endothelial cells are capable of generating ROS via NADPH oxidase. It has been shown 
that all components of phagocyte-type NADPH oxidase are expressed in endothelial cells at 
both mRNA and protein level (Bayraktutan et al., 2000; Brandes et al., 2002). Although the 
homologues ofp47phox and p67phox (NoxOl and NoxAl) are not present in endothelial celis, 
the fact that functional NADPH oxidase does exist in Nox2 knockout mice indicates 
endothelial cells may contain other Nox molecules involved in ROS generation. It is 
identified as Noxl and Nox4, but their actual function remains unclear (Byrne et al., 2003; 
Lambeth et aI., 2000; Yuzawa et al., 2004). 
In spite of being structurally highly identical between endothelial and neutrophil oxidases, 
functionally there are still some differences. The first systematic characterization of 
endothelial NADPH was reported by Li and Shah (Li and Shah, 2002). They showed that: 
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1) The endothelial oxidase constitutively generates comparatively low level of superoxide 
even in unstimulated cell, but its activity can respond to the stimulation by various agonists. 
2) The majority of superoxide in endothelial cells is generated intracellularly, which is in 
contrast with neutrophil superoxide generation that is predominantly generated 
extracelluarly. 
3) A substantial proportion ofNADPH oxidase subunits are pre-assembled in unstimulated 
endothelial cells, whereas the assembled NADPH oxidase complex is mainly found in 
stimulated neutrophils. 
4) A large scale of Nox2-based oxidase is associated with intracellular cytoskeleton, 
especially locating in a perinuclear distribution in endothelial cells, whereas Nox2 is 
predominantly distributed in the plasma membrane in neutrophils. 
In addition to these findings, the substantial expression of Nox4 has been observed in 
endothelial cells and it is suggested that this homologue to Nox2 may contribute to the 
basal continuous generation of ROS as well (Ago et aI., 2004). The relative roles of these 
two isoforms in endothelial cells remain to be illustrated. Additionally, a recent report has 
shown that, in resting endothelial cells, NADPH oxidase subunits are pre-assembled, which 
is in line with previous work; but it showed that the functional enzyme also locate in 
membrane raft, specifically in caveolae (Yang and Rizzo, 2007). 
1.7.2 Reguation Activation of Endotheial NADPH Oxidase 
Not only does endothelial NADPH oxidase continuously generate a low level of ROS 
production, but also its activity is regulated by a large of stimuli, including: mechanical 
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forces such as oscillatory shear stress, agonists of G-protein-coupled receptors such as 
angiotensin II or ET-I, growth factors such as vascular endothelial growth factor (VEGF), 
cytokines such as TNFa or IL-I, metabolic factors such as increased glucose, insulin, 
hypoxia-reoxygenation and oxidised lipids (Ray and Shah, 2005). Two general mechanisms 
are involved in an increase of NADPH oxidase activity: one is a rapid phosphorylation 
modification of NADPH oxidase regulatory subunits; the other is the increased expression 
levels of oxidase subunits. 
The regulatory subunit p47phox is involved in activation of the endothelial NADPH oxidase. 
Like phagocytes, the p47phOX in endothelial cells translocates to the Nox2/p22phox 
heterodimer to form an assembled complexes in response to stimulation. This is 
demonstrated by the study showing that during angiotensin II-stimulated endothelial 
NADPH oxidase activation, p47phOX undergoes a rapid serine phosphorylation, which is 
accompanied by an increased p47phox_p22PhOX binding and a subsequent increase in ROS 
generation (Li and Shah, 2003a). Although endothelial NADPH oxidase is present as a 
preassembled enzyme complexe leading to a constitutive low level of ROS production, the 
enhanced activity by agonists such as angiotensin II seems to require the formation of 
additional complexes (Harrison et aI., 2003b). Endothelial p47phox is capable of being 
phosphorylated by PMA stimulation, suggesting the phosphorylation of p47phox is PKC-
dependent (Li et aI., 2002b). This is supported by the evidence that the activation of 
NADPH oxidase can be induced by TNFa in lung vascular endothelial cells via PKCC-
dependent pathway (Frey et aI., 2002).The role of p47phox in endothelial NADPH oxidase 
activation has been further confirmed using tissues isolated from p47Phox knockout mice, 
where endothelial NADPH oxidase failed to respond to agonist-induced actue stimulation 
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such as angiotensin II and TNF l'r (Li et aI., 2002b; Li and Shah, 2003a), and chronic 
stimulation such as oscillatory shear (Hwang et aI., 2003). Nevertheless, either angiotensin 
II-induced MAPK activation (Li and Shah, 2004), or TNFa--induced JNK activation (Xu et 
aI., 2002), or redox-mediated gene expression (Brandes et aI., 2002) in endothelial cells also 
requires the participation of p47phOX. In endothelial cells, TNFa is able to induce the 
association of p47phOX with TNF receptor-associated factor 4 (TRAF4) leading to a 
downstream of activation of JNK. The binding of p47phox to TRAF4 may therefore be play 
an important role in localising the ROS signal to proteins associated with TRAF4 (Glauner 
et aI., 2002). 
A more complex role for p47phox has been revealed by investigation on coronary 
microvascular endothelial cells (CMEC) isolated from p47phox-l- mice or transient 
knockdown of p47phOX by antisense cDNA transfection (Frey et aI., 2002; Harrison et aI., 
2003a; Li and Shah, 2004). Interestingly, neither p47phox knockout endothelial ceIls nor 
wild-type endothelial ceIls with transient depletion of p47phox elicit a slight increase in basal 
ROS production compared to wild-type control cells. However, in acute response to PMA, 
TNFa, or angiotensin II, a failure of NADPH oxidase activity was observed in p47Phox-l-
endothelial cells. In addition, angiotensin II-induced endothelial dysfunction was also 
abrogated in aortic rings isolated from p47phox-l- mice. In a recent report, it has been shown 
that p40PhOX exists as a prephosphorylated state in resting endothelial cells and is involved in 
the regulation of agonist-induced ROS production through its dynamic dephosphorylation 
and rephosphorylation. In this study, a slightly but significantly increased ROS proudction 
was also observed in p47phOX-I- endothelial cells, which is accompanied by an increased 
expression level of p40PhOX, compared to wild-type control cells (Fan et aI., 2009). It 
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indicates that the slightly higher basal ROS production in p47pohx-l- endothelial cells may be 
partically due to the increased expression level of p40PhOX. 
Collectively, these results suggest that p47phox is important for agonist-induced endothelial 
ROS production, and its serine phosphorylation plays an essential role in regulation of 
endothelial NADPH oxidase activity. 
1.8 Hypothesis and Aims 
The importance of p47phOX phosphorylation has been demonstrated to playa vital role in 
translocation of p40PhOX and p67PhOX to the membrane-integrated cytochrome b to form an 
activated enzyme complex in leukocytes. Though the phagocyte-type NADPH oxidase is 
also expressed in endothelial cells, ROS generated from both cell types are functionally 
different, suggesting a divergent mechanism ofNADPH oxidase activation. Our hypothesis 
is that p47phOX has multiple serine phosphorylation sites, and endothelial cells may have a 
different phosphorylated pattern in comparison with what was reported in phagocytic cells. 
Thus, the aim of my PhD project is to investigate the mechanisms of p47phox seirne 
phosphorylation in the regulation of NADPH oxidase activation in endothelial cells, in 
particular to identify the critical serine phosphorylation sites in p47PhOX, which may playa 
key role in the activation of endothelial NADPH oxidase. 
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Chapter 2: Materials and Methods 
2.1 Materials 
Table 2.1: The list of materials 
Materials Supplier Catalogue N urn ber 
Acrylamide Fisher Scientific BPE141O-1 
Ale I restriction enzyme New England Biolab R0652S 
Ammonium persulfate Sigma A9164 
Ampicillin Fisher Scientific BPE1760-5 
Ascorbic acid Sigma A4403 
Alpha-tubulin antibody Sigma T6074 
(mouse monoclonal) 
Bio-Rad Bradford protein dye Bio-Rad 500-0006 
BsiWI restriction enzyme New England Biolab R0553S 
Casein hydrolysate Sigma 22090 
Clonetics EGM-2-MV medium Kit Lonza CC-3202 
CM-H2DCFDA Invitrogen C6827 
DH5a E.coli competent cells Invitrogen 12297016 
DMEM (high glucose) Sigma D5796 
DMEM (low glucose) Sigma D5546 
DMSO Sigma D2650 
DNase II Sigma D8764 
DPI Sigma D2926 
Eae I restriction enzyme New England Biolab R0508S 
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Table 2.1: to be continued 
Materials Supplier Catalogue Number 
ERK1I2 antibody (rabbit polyclonal) Santa Cruz SC-93 
FBS Invitrogen 16000044 
Ethidium bromide Sigma E7637 
G418 Invitrogen 11811064 
Gelatin Sigma G1393 
GenElute Endotoxin-Free Midiprep Sigma PLED35 
kit 
GenElute Plasmid Miniprep kit Sigma PLN350 
GoTaq Flexi PCR Kit Promega M8291 
Hanks' Buffered Salt Solution Sigma D8537 
Human lung microvascular Lonza CC-2527 
endothelial cells 
Hydrocortisone Sigma HOl35 
IPTG Sigma 16758 
JNK antibody (rabbit polyclonal) Santa Cruz SC-474 
L-NAME Sigma N5751 
Lucigenin Sigma B49203 
Luria Agar Sigma L3147 
Luria Broth Sigma L3522 
MouseEGF Sigma E4127 
Mouse IGF-l Sigma 18779 
Mouse VEGF Sigma V4512 
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Table 2.1: to be continued 
Materials Supplier 
NADPH Sigma 
Nae I restriction enzyme New England Biolab 
Nhe I restriction enzyme New England Biolab 
Oxypurinol Sigma 
p38 MAPK (rabbit polyclonal) Santa Cruz 
p47phOX knockout mice on 129P2/S2 Medical Research Council 
pcDNA3.1/Zeo- Invitrogen 
PEl Polysciences Inc 
p-ERKl12 antibody Santa Cruz 
(mouse monoclonal) 
p-JNK antibody (mouse monoclonal) New England Biolab 
p-p38 MAPK antibody (rabbit New England Biolab 
monoclonal) 
Protease inhibitor cocktail Sigma 
Proteinase K Roche Applied Science 
Pst I restriction enzyme New England Biolab 
Puromycin Calbiochem 
PVDF Sigma 
QuikChange Multi Site-Directed Agilent Technologies 
Mutagenesis kit 
Protein molecular marker Lonza 
Rotenone Sigma 
Catalogue Number 
N7785 
R0190S 
R0131S 
06881 
SC-7149 
V86520 
23966-2 
SC-81492 
9255S 
9215S 
P8340 
03115879011 
R0140S 
540411 
P2813 
200515 
50550 
R8875 
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Table 2.1: to be continued 
Materials Supplier Catalogue Number 
Sac I New England Biolab R0156S 
Sma I New England Biolab R0141S 
SVEC4-10 ATCC CRL-2181 
Tiron Sigma 89460 
TNFa (human) Roche Applied Science 11371843001 
TNFa (mouse) Roche Applied Science 11271156001 
Trypan blue Sigma T8154 
Trypsin-EDTA Sigma T3924 
Wild-type C57BLl61 strain mice Charles River 
Xanthine oxidase Sigma X4500 
X-gal Sigma 16664 
Yeast extract Sigma Y1625 
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2.2 Site-Directed Mutagenesis 
In vitro site-directed mutagenesis is a powerful tool for understanding protein structure-
function relationships by modifying protein coding sequences (Griendling et aI., 2000; 
Shen, 2002). This technique has been widely applied to investigate the roles of 
phosphorylation in protein function. As mentioned in Chapter 1, p47phol( serine 
phosphorylation is a key step for Nox2 activation. To reveal critical phosphorylation 
residues of p47phoX, the substitution of several serines for alanines were established by using 
the QuikChange Multi Site-Directed Mutagenesis kit (Agilent Technologies). According to 
manufacturer's instructions, the whole procedures can be briefly divided into three steps: 1) 
to synthesise mutant strands by multiple rounds of thermal cycling reactions; 2) to 
eliminate parent plasmids with Dpn I endonuclease and 3) to transform single-stranded 
DNA (ssDNA) mutant into competent cells to form a duplex mutant plasmid (Figure 2.1). 
Figure 2.1: Diagrammatic description of multi site-directed mutagenesis. 
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2.2.1 Mutagenic Primer Design 
The mutagenic primers were designed to incorporate the point nucleotide mutation as 
required. The general guideline for the primer design was followed according to the 
manufacturer's instructions (Revision A) provided in the QuikChange Multi Site-Directed 
Mutagenesis kit (Agilent Technologies). 
The primer design guideline: 
1) Mutagenic primers should be designed to cover the desired point mutation with the 
length of 25 to 45 nucleotide bases. 
2) The point mutation should be close to the middle of each primer with around 10-15 bases 
of template-complementary sequence on both sides. 
3) The melting temperature of each primer should be above 75°C. For simultaneous 
mutagenesis, optimum primer sets should have similar melting temperature. The following 
formula is specifically used for estimating the melting temperature of mutagenic primers. 
For calculating T m: 
T m = 81.5 + 0.41 (%GC) - 6751N - %mismatch 
(N is the primer length in bases; Values for %GC and %mishmatch are whole numbers) 
4) Primers should have a minimum of 40% GC content and terminate at least in one C or G 
base at the 3' -end. 
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5) For simultaneous mutagenesis, pnmers are preferentially designed with similar or 
identical length of sequence. If there are more than 20% difference in length, the amount of 
each primer used for PCR will be adjusted based on equal mole rather than equal mass. 
6) The primer sequences are finally analysed by software OligoAnalyzer 3.0 (Integrated 
DNA Technologies, Coralville, IA) to check the stability of potential secondary structure 
formation, the melting temperature of which should be ideally lower than 60°C. 
Nine sense oligonucleotides (Table 2.1), containing human p47phox cDNA (GenBank: 
AF330627.1) point mutations, were designed according to the primer design guideline 
mentioned above. With those point mutations, the codon for serine can be converted to the 
codon for alanine. Alanine is a neutral amino acid showing a similar three-dimensional 
molecular structure compared to serine, but incapable of undergoing phosphorylation. To 
facilitate mutant screening, restriction endonulcease digest site was also simultaneously 
created or abolished nearby the desired nucleotide substitution by silent mutation, which 
has no effect on amino acid sequence with an alteration of its genetic code. Therefore, the 
successful mutagenesis can be verified by observing the change of band sizes with 
corresponding restriction enzyme digest (Table 2.1). All oligonucleotide primers were 
synthesised and purified by high performance liquid chromatography (Eruofins MWG 
Operon, Ebersberg, Germany). 
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Table 2.2: Designed sense oligonucleotides for mutagenesis of p47phox• 
Mutation 
S303.304A 
S3\SA 
S320A 
S328A 
S345A 
S348A 
S359A 
S370A 
S379A 
5' -CCG CCC CGC AGG GCG GCC ATC CGC AAC GCG-3' 
5' - AGC ATC CAT CAG CG A GCT CGG AAG CGC CTC AGC -3' 
5' - CGG TCG CGG AAG CGG CTA GCC CAG GAC GCC TAT CG- 3' 
5' - C TAT CGC CGC AAC GCC GT" CGT TIT CTG CAG CAG C-3' 
5'- CG CGG CCG GGe CCG CAG GCC CCC GGG AGC C-3' 
5'-CG CAG AGC ,G.C~.QQ !\ Gee CCG eTC GAG GAG G-3' 
5'-CAG ACG C,AO .. G.O.C..QCT AAA CCG CAG CCG-3' 
5'-CCC CCG CGG CCG Gec Gce GAC CTC ATC CTG-3' 
5'-CTG AAC CG~.I.O.C .. O.CC GAG AGC ACC AAG CGG-3' 
Restriction Enzvme 
+Eae I 
+Sac I 
+Nhe I 
+BsiW I 
+Apa I 
-Sma J 
-Afe I 
+Nae I 
-Pst I 
Primers designed for human p47phox serine (S) to alaine (A) substitution were accompanied by the changes of restriction enzyme 
digest site. Red letters indicate the alteration of nucleotides compared with wild-type p47phox eDNA. Underline represents an 
introduced restriction enzyme digest site, and dotted line represents an abolished original restriction enzyme digest site. 
2.2.2 Mutant Strand Synthesis 
The recombinant human p47phox cDNA sequence subcloned into pcDNA3.lIZeo-
(Invitrogen) at Xba I and Hind III sites was a kind gift from Clark RA, University of Texas 
Health Science Center in San Antonio. The whole circular construct has 6327 base pairs 
(bp) in size. Prior to the mutant strand synthesis reaction, the amplification of p47phox 
plasmid was prepared using standard transformation method (chapter 2.3.2), isolated from 
E.coli (DH5a strain) and purified using plasmid miniprep kit (chapter 2.2.6). 
Mutant strand synthesis was carried out using a polymerase chain reaction (PCR)-based 
method recommended by site-directed mutagenesis kit's instructions. Briefly, 100ng of 
double strand DNA template and 100ng of each mutagenic primer were mixed with 2.5/l1 
lOx Quikchange buffer, 0.5).11 Quiksolution, 1).11 dNTP mix and 1).11 Quikchange multi 
enzyme blend (2.5U/).11) featuring P/uTurbo® DNA polymerase (provided by QuikChange 
Multi Site-Directed Mutagenesis kit). The final 25/l1 of reaction mixture in 0.2ml thin-wall 
PCR tube was placed in a hot-top assembly thermal cycler and cycling parameters were set 
as shown in Table 2.3. 
Table 2.3: Cycling parameters of peR for mutagenesis. 
Segment Cycles Temperature Time 
1 95°C 1 minute 
95°C 1 minute 
2 30 55°C 1 minute 
65°C 2 minuteslkb of plasmid length 
3 1 4°C ----------
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2.2.3 Mutagenesis Efficiency Control 
The Quikchange Multi control primer mix and template (provided by QuikChange Multi Site-
Directed Mutagenesis kit) were used to test the efficiency of simultaneous site-directed 
mutagenesis at three independent sites. The Quikchange Multi control template was 
initially modified to contain stop codons at three different positions in the LacZ coding 
sequence, and three control primers were applied to restore these stop codons to the codons 
found in the original LacZ gene (Figure 2.2) . Therefore, the colonies containing triple-
mutated vector showed blue colour on Luria Agar containing 5-bromo-4-chloro-3-indolyl-
p-D-galactopyranoside (X-gal) in the presence of the inducer isopropyl- l-thio-P-D-
galacytopyranoside (lPTG). 
Figure 2.2: QuikChange Multi control plasmid and control primer 
sequences. 
Gin 
Mutagenic CC ATG ATT ACG CCA AGC GCG I ~~~I TTA ACC CTC Primers ATG ACC ATG ATT ACG CC A AGC GCG TTA ACe CTC 
STOP 
Control Plasmid 
(LacZ'l 
AC T AAA GGG AAC AAA AGC TGG AGC TCC ACC GCG GTG 
GCG GCe GCT CTA GAA CTA GTG GA- CCC CCG GGC TGC 
TCG ATA TCA AGC I~I TCG ATA CCG TCG ACC 
AGG AAT -CG ATA -CA AGC TCG ATA CCG TCG ACC 
STOP 
TCG AGG GGG GGC CCG I~ I CCC AAT TCG cce TAT 
TCG AGG GGG GGC CCG TA ecc AA- TCG CCC TAT AG T 
STOP 
The Quikchange Multi control primer sequences are shown above their corresponding sites 
in the control plasmid with the stop codons reverted by the control mutagenesis reaction 
boxed (Adapted from QuikChange Multi Site-Directed Mutagenesis kit 's instruction). 
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2.2.4 Elimination of Template DNA 
DH5a is one of E.coU strains containing a DNA adenine methyltransferase (dam) gene, 
which can methylate adenine residues in the 5' -GA TC-3' sequence. This specific 
methylated and hemimethylated 5'-Gm6ATC-3' sequence can be targeted and digested by a 
restriction endonuclease Dpn I. To eliminate parental template isolated from E.coU DH5a, 
1 III of 10UIIlI Dpn I restriction enzyme (provided by QuikChange Multi Site-Directed 
Mutagenesis kit) was added directly to the thermal cycling product with gently and 
thoroughly mix by pipetting. After a brief centrifugation (12,000 x g, 1 minute), the 
reaction mixture was incubated at 37°C for 90minutes. The digested product containing 
synthesised mutant strand (unmethylated DNA) was used for the following transformation. 
2.2.5 Transformation of XLIO-Gold Ultracompetent Cells 
XLIO-Gold ultracompetent E.coU cells (provided by QuikChange Multi Site-Directed 
Mutagenesis kit) were gently thawed on ice and transferred to a prechilled 15ml BD Falcon 
polypropylene round-bottom tube. In each tube, 2111 of the p-mercaptoethanol mix 
(provided by QuikChange Multi Site-Directed Mutagenesis kit) was added to the 45J..lI of 
the ultracompetent cells. The tube was placed back on ice for 10 minutes, with gentle 
swirling every 2 minutes. Dpn I-treated DNA (1.51ll) from each mutagenesis reaction was 
then transferred directly into a separate aliquot of the ultracompetent cells and the 
transformation reactions were gently swirled prior to further 30 minutes' ice chilling. The 
transformation mix was heat-shocked in a 42°C water bath for 30 seconds and then 
incubated on ice for 2 minutes. The recovery of cells was carried out by adding 0.5ml of 
NZv+ broth (lOgll casein hydrolysate, 5g11 yeast extract, 5g11 NaCl, 0.4% (w/v) glucose, 
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12.5mM MgCh and 12.5mM MgS04, pH 7.5) to each 14ml Falcon tube and incubating 
them at 37°C for 1 hour with shaking at 250rpm. Finally, lOJlI of transformed cells diluted 
in 100JlI NZY+ broth was spread on Luria Broth (LB) agar (l0g/1 NaCI, 109/1 tryptone, 5g/1 
yeast extract and 20g/1 agar, pH 7.0) containing 1 OOJlg/ml ampicillin (Fisher Scientific) in 
100mm petri dishes and incubated at 37°C. 16 hours later, single colony was randomly 
selected for subculturing in LB-ampicillin (lOOJlg/ml) medium at 37°C with 250rpm 
shaking for overnight. 
For the mutagenesis controls (Chapter 2.2.3), mutated pUC18 vector was also transformed 
into ultracompetent cells and spread on LB-ampicillin agar plates that was prepared with X-
gal (80Jlg/ml, Sigma) and 20mM IPTG (Sigma). The mutagenesis efficiency was 
determined by calculating the percentage of blue colonies in the dish. 
2.2.6 Mini-Prep of Plasmid DNA 
The recombinant plasmid DNA amplified by genetically modified E.coli (XLI0-Gold strain) 
was purified using the GenE lute Plasmid Miniprep kit (Sigma). In accordance with 
Miniprep kit's instructions, 3ml of the overnight-cultured cells was collected by 
centrifugation at 13,000 x g for 1 minute. The supernatant was discarded and the cell pellet 
was thoroughly resuspended with 200JlI of the Resuspension Solution containing 100Jlg/ml 
RNase A (provided by the Plasmid Miniprep kit) by pipetting. Cell homogenate was then 
added with 200JlI of Alkaline Lysis buffer, followed by gentle inversion mix for 6 times. 
Once the mixture became clear and viscous (within 5 minutes), cell lysis reaction was 
ceased by adding 350JlI of NeutralisationIBinding Buffer. After inverting the tube 5 times, 
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cell debris was pelleted by centrifuging at 13,000 x g for 10 minutes. The supernatant was 
then separated from the cloudy, viscous precipitate (cells debris, proteins, lipids, sodium 
lauryl sulphate and chromosomal DNA) and transferred to a GenE lute Miniprep Binding 
Column which was prerinsed with 500~1 of the Column Preparation Solution. With 13,000 
x g centrifuge for 1 minute, plasmid DNA was retained and bound to the column membrane. 
The DNA-bound column was then washed in 750~1 Wash Solution containing ethanol by 
13,000 x g centrifuge for 1 minute. The plasmid DNA was finally eluted in I 00~1 of 
deionised H20 (All buffers and columns were provided by GenElute Plasmid Miniprep kit). 
The DNA concentration was measured by the NanoDrop ND-IOOO Spectrophotometer 
(Thermo Scientific, UK), and the purity of DNA was determined by the ratio of absorbance 
at 260nm (DNA) to 280nm (protein). The plasmid DNA with purity above 1.8 was directly 
used for restriction digest and sequencing. 
2.2.7 Restriction Digest Analysis 
Recombinant plasmid DNA mutants were verified by restriction digest analysis using 
restriction endonucleases (New England Biolab) listed in the table 2.2. Following the 
manual instructions, 1-IO~g plasmid digestion was prepared by mixing appropriate lOx 
NEBuffers (lOOJlglml Bovine Serum Albumin was applied for some enzymatic digestion) 
with corresponding restriction digest enzymes in a total volume of 20JlI, and incubated at 
optimal temperature for several hours (Details in Table 2.4). Digestive products were mixed 
with 6x blue/orange loading dye (Promega, UK) and then loaded into 1-4% agarose (Fisher 
scientific) gels in Tris-Acetate-EDTA (TAE) buffer (40mM Tris-Acetate and ImM EDTA) 
containing nethidium bromide (500ng/ml, Sigma). lkb DNA ladders (Invitrogen and 
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QIAGEN) and IOObp DNA ladders (QIAGEN) were simultaneously loaded to reveal the 
bands of size in digestive products. The gel was run at constant 100 volts for 40 minutes in 
Ix TAE buffer. The DNA bands were subsequently visualised under ultraviolet. 
Ix NEBuffer Recipe: 
NEBuffer 1: 
10mM Bis-Tris-Propane-HCI 
10mMMgCh 
ImM Dithiothreitol 
pH 7.0 at 25°C 
NEBuffer3: 
100mMNaCl 
50mM Tris-HCl 
10mMMgCh 
1 mM Dithiothreitol 
pH 7.9 at 2SoC 
NEBuffer2: 
50mMNaCl 
IOmM Tris-HCl 
10mMMgCh 
ImM Dithiothreitol 
pH 7.9 at 2SoC 
NEBuffer4: 
SOmM Potassium acetate 
20mM Tris acetate 
10mM Magnesium acetate 
ImM Dithiothreitol 
pH 7.9 at 25°C 
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Table 2.4: List of conditions for restriction digest analysis. 
Enzyme Unit Amount of Plasmid Digestion Percentage of 
Enzymes Buffers BSA for Digestion for Digestion Temperature Time Agarose Gel 
Ale I I x NEBuffer 4 -------- 2 units IJ.lg 37°C 3 hours 1% 
ApaI Ix NEBuffer 4 I 00 J.l g/ml 4 units IJ.lg 2SoC 3 hours 1% 
BsiWI Ix NEBuffer 3 -------- 2 units SOOng SSoC 2 hours 1% 
Eae I Ix NEBuffer 1 -------- 10 units SJ.lg 37°C 8 hours 2.S% 
NaeI Ix NEBuffer 1 -------- 10 units lOJ.lg 37°C 6 hours 4% 
NheI I x NEBuffer 2 100J.lg/ml S units 2J.lg 37°C 2 hours I.S% 
Pst I Ix NEBuffer 3 1 00 J.l g/m I 8 units 5J.lg 37°C 3 hours 2% 
Sac I Ix NEBuffer 1 100J.lg/ml S units IJ.lg 37°C 2 hours 1% 
Sma I Ix NEBuffer 4 -------- S units 2J.lg 2SoC 2 hours 1% 
Restriction enzyme unit: one unit is defined as the amount of enzyme required to digest 1 J.lg of DNA in 1 hour at optimal temperature 
in a total reaction volume of SOJ.l1. The amount of plasmid DNA used for each mutant screening digestion varied, depending on the 
expected size of different bands. The smaller band was expected to be seen, the more plasmid DNA and restriction digest enzyme was 
applied for digestion with longer incubation time. The detail of individual mutant digestion was shown in Chapter 3. 
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2.2.8 Sequencing 
To verify mutant plasmids selected from restriction digest analysis, the mutant DNA was 
conformed by sequencing. The sequencing service was provided by Eruofins MWG Operon, 
London, UK. The sequencing of plasmid DNA started with T7 promoter (5'-TAA TAC 
GAC TCA CTA TAG GG-3'), which locates before the starting codon of recombinant 
p47phOX• As the mutation sites are located at 900bp after starting codon, it is quite possible 
that sequencing could not cover the mutation sites. Thus, another sequencing primer was 
designed as 5'-GGT CAT CAG GAA AGA CGA CG-3' (Eruofins MWG Operon, London, 
UK), which resides 92bp before the sequence of Ser303/304 in recombinant human p47phox• 
All sequencing results were finally checked in comparison with human p47phox GenBank 
sequence (GenBank: AF330627.l). 
2.3 Amplification of plasmid DNA 
2.3.1 Preparation of Competent Cells 
To prepare competent cells for transformation, E.coli (DH5a. strain, Invitrogen) was 
streaked on to an LB agar (Sigma) plate and cultured overnight at 37°C. A single colony 
was inoculated into 10ml LB medium (Sigma) in a 50ml Falcon tube, and incubated 
overnight at 37°C with 225rpm shaking. The day after, cells were subcultured at 1 :50 
dilution by inoculating 1 ml of cells into 50ml of LB medium containing 20mM MgS04 in 
an autoclaved 250ml conical flask. Cells were continuously grown until the absorbance of 
culture reached 0.4-0.6 at OD600, and immediately chilled on ice. Ten minutes later, cells 
were collected by centrifugation at 4,500 x g at 4°C for 10 minutes, using a prechilled rotor 
(To achieve high quality of competent cells, the following procedures were carried out at 
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4°C). Cell pellet was gently resuspended in filter-sterilised IOml (l/5 th of the original 
culture volume) of Transformation buffer 1 (30mM potassium acetate, 100mM RbCI, 
IOmM CaCI2, 50mM MnCh, 15% glycerol, pH to 5.8 with acetic acid) and subsequently 
chilled on ice for 30 minutes. Cells were pelleted again by centrifugation at 4,500 x g for 10 
minutes, and gently resuspended in 2ml (l/25 th of the original culture volume) of 
Transformation buffer 2 (lOmM MOPS, 75mM CaCh, 10mM RbCI, 15% glycerol, pH to 
6.5 with 1M KOH) and chilled on ice for 15 minutes. Finally, the competent cells were 
made in 100111 aliquot per sterilised tube, snap-frozen in liquid nitrogen and stored at -80°C 
immediately. 
The transformation efficiency was also tested by performing standard transformation 
method (Chapter 2.3.2), and calculated as colony forming unit (CFU) per Ilg plasmid DNA. 
Transformation efficiency (CFU/llg) = 
____________________________ X -------------- X dilution factor CFU on plate 
1000ng 
ng of plasmid plated 
2.3.2 Transformation of DHSa Competent Cells 
DH5a competent cells (l001l1 aliquot) were thawed on ice and transferred into a pre-chilled 
sterile 14ml polypropylene round bottom tube. Ing of plasmid DNA was directly added 
into cells and mixed by gently tapping the tube several times. The tube was placed back on 
ice and incubated for 10 minutes. Cells were then heat-shocked for 50 seconds at exactly 
42°C in the water bath, immediately followed by ice-chilling the tube for 2 minutes. With 
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addition of9001l1 LB medium (IOg/1 tryptone, Sg/l yeast extract and 109/I NaCI, pH to 7.S), 
cells were incubated at 37°C with a 2S0rpm shaking. One hour later, 100111 of 
transformation mix was plated onto LB agar plate with an appropriate antibiotic 
(pcDNA3.lIZeo-: 100llg/mi ampicillin) and incubated overnight at 37°C with the plate up 
side down. The day after, single colony was inoculated into LB-antibiotic medium for 
subculture. 
2.3.3 Glycerol Stocks of Transformed E.coli 
The plasmid-transformed E.coli from single colony was subcultured for 16 hours at 37°C in 
LB-antibiotic medium (pcDNA3.lIZeo-: lOOIlg/ml ampicillin) with 2S0rpm shaking. O.Sml 
of E.coli cells was mixed with equal volume of sterilised SO% glycerol in a I.Sml 
eppendorf tube. After a thorough inversion mixing, transformed E.coli cells were 
immediately stored at -80°C and ready for subculture. 
2.3.4 Midi-Prep of Endotoxin-Free Plasmid DNA 
Transformed E.coli DHSa in glycerol stock was directly inoculated into 100ml of LB 
medium with an appropriate antibiotic (pcDNA3.lIZeo-: IOOIlg/ml ampicillin) in a 
sterilised 2S0ml conical flask, and incubated at 37°C with 200rpm orbital shaking overnight. 
The plasmid DNA was separated and purified using the GenElute Endotoxin-Free Midiprep 
kit (Sigma). 40ml of recombinant E.coli culture cells were harvested by centrifugation at 
S,OOO x g for 10 minutes. The medium supernatant was discarded and the cell pellet was 
thoroughly resuspended with 1.2ml Resuspension Solution with IOOIlg/ml RNase A. 
Resuspended cells were then subjected to an alkaline-SDS lysis procedures (within S 
67 
minutes) using 1.2 ml Lysis Solution, followed by an neutralisation step using 0.8ml of 
Neutralisation Solution containing low pH of potassium acetate. Cell debris was 
precipitated by centrifuging the tube at 15,000 x g for 15 minutes at 4°C. The cleared lysate 
separated from cell debris was transferred into a 15ml conical tube and mixed with 300J.lI of 
pre-chilled Endotoxin Removal Solution. The mixture was chilled on ice for 6 minutes with 
5 times of tube inversion every 2 minutes. The light blue and clear solution incubated at 
37°C turned cloudy in 5 minutes, and then centrifuged at 5,000 x g for 5 minutes. The 
upper clear solution containing plasmid DNA was transferred to a new 14ml tube (The 
endotoxin removal step was repeated once). After twice Endotoxin-removal steps, 0.8ml of 
DNA Binding Solution was then added to the clear lysate, and the mixture was spun down 
in a Midi-binding column at 5,000 x g for 2 minutes. After washing the DNA-bound 
membrane in the column with 3ml Wash Solution, the DNA was finally eluted in Iml 
Endotoxin-Free water (All buffers and columns were provided by GenElute Endotoxin-Free 
Plasmid Midiprep kit). The concentration of plasmid DNA was determined by the 
NanoDrop ND-l 000 Spectrophotometer (Thermo Scientific, UK), and the purified plasmid 
(A2601 A2so above 1.8) was used for transfection. 
2.4 Animals 
The p47phOX knockout mice on 129P2/S2 background were obtained from the Medical 
Research Council (UK), and housed in the sterile cage with free access to standard chow 
diet and water. All mice were maintained at a constant temperature of 22± 1°C, 45-55% 
humidity and a 12-hour light/12-hour dark cycle. All animal experiments were carried out 
in accordance with the Guidance on the Operation of Animals (Scientific Procedures) Act, 
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1986 (Her Majesty's Stationery Office, UK). Generation of p47phox knockout mice was 
established by inserting a neomycin resistance gene into the third exon of the p47phox gene 
to disrupt protein expression (Harbord et aI., 2002). 
2.5 Genotyping 
The genotype of mice was verified by performing PCR-based genotyping. The tail tip (2-
3mm) of each mouse was snipped with clean scissors and placed in a pre-labelled DNase-
free 1.5ml microcentrifuge tube. Simultaneously, each individual was also labelled with 
specific marker by ear clipping or tail marking. The tissue was overnight digested in 150111 
tail lysis buffer containing 50mM KCI, 1.5mM MgCh, 10mM Tris.HCI (pH 7.5), 0.01 % 
gelatin, 0.45% Nonidet P-40, 0.45% Tween-20 and 200ug/ml proteinase K (Roche Applied 
Science) at 55°C with shaking agitation. Preceded by heat deactivation of the enzyme at 
950C for 5 minutes, samples were briefly vortexed and centrifuged at 13,000 x g for 5 
minutes to pellet debris, and the supernatant (genomic DNA) was used for PCR analysis. 
Table2.5: The sequence of primers for PeR-based genotyping. 
Genotype 
Wild-type Forward 
p47phOX 
knockout 
Reverse 
Forward 
Reverse 
Primer sequence 
5' -GGCAGTTTCAGGTCA TCAGGCCGC-3' 
5' -GGCCGGCGAGATCCACACAGAGAAC-3' 
5' -A TTCACCGAGATCTACGAGTTCCATGT -3' 
5' -TGCGTGCAATCCATCTTGTTCAATGG-3' 
peR product 
size 
400bp 
1200bp 
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Two pairs of primers, designed to identify the genotype of mice, were synthesised from 
Eurofins MWG Operon, and the sequence information was obtained from Medical 
Research Council, UK. The PCR mix for each sample was made up of Ix GoTaq Flexi 
buffer (Promega), 2mM MgCh, O.2mM each dNTP mix, 0.8~M forward primer, 0.8~M 
reverse primer, 1 ~l supernatant from digested tissue, I unit GoTaq DNA polymerase 
(Promega) and H20 in a total 25~1 volume. Two separate PCRs were prepared for each 
sample by using two different sets of primers (Table 2.5) in the PCR mix and 
simultaneously performed according to thermal cycling parameters listed in Table 2.6. 
Table 2.6: Thermal parameters of peR for genotyping. 
Step Objective Temperature Time N umber of Cycles 
1 Initial Denaturation 95°C 2 minutes 1 cycle 
2 Denaturation 95°C 90 seconds 
3 Annealing 65°C 30 seconds Step 2 to 4: 38 cycles 
4 Extension noc 90 seconds 
5 Final Extension noc 5 minutes 1 cycle 
6 Soak 4°C 
Finally, PCR products were directly loaded onto a 1.5% agarose gel dissolved in 1 x T AE 
buffer with SOOng/ml ethidium bromide. To identify the band size, S~l 100bp DNA ladder 
(QIAGEN) was also loaded in each gel. The gel was run at constant 100 volts for 40 
minutes in 1 x T AE buffer and DNA bands were then detected by exposing the gel in a 
standard 300nm UV transilluminator. The PCR product produced from the wild-type allele 
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of the p47phOX gene was approximately 400bp in size; whereas the approximate 1200bp 
PCR product was formed from the genetic modified p47phox knockout gene. 
2.6 Back-Crossing of p47phox Knockout 129P2/S2 Strain Mice with Wild-
type C57BL/6J Stain Mice 
There is major genetic variation within the 129 "family" of mice, which has led to an 
update of the nomenclature and a division of the substrains into three major groups: 
parental substrains (l29P), steel substrains (129S) and "teratoma" substrains (129T). 
Nevertheless, mice on 129 strain are widely used in the production of targeted mutations 
due to the availability of multiple embryonic stem cell lines derived from them. C57BLl6J 
mice are the most widely used inbred strain and the first to have its genome sequenced. 
Also, C57BLl6J strain is a good animal model for cardiovascular research, as these mice 
are also susceptible to many cardiovascular diseases such as diet-induced obesity, type II 
diabetes and atherosclerosis. Thus, p47phox knockout gene in 129P2/S2 background mice 
was determined to be back-crossed into C57BLl6J strain. 
A mouse has 40 chromosomes and its p47phox gene locates to chromosome 7, which is an 
autosome. The male p47phox knockout mice on 129P2/S2 background were mated with 
wild-type female C57BLl6J mice (Charles River UK Ltd., Margate, UK). The first 
generation of mice was all heterozygote (p47phox+I-). The male p47Phox heterozygote mice (at 
least 6 weeks old) were then bred with wild-type female C57BLl6J. The litters from first 
back-crossing were either wild-type male, or wild-type female, or p47phox heterozygote 
male, or p47phox heterozygote females. The p47phox heterozygote male were continuously 
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bred with wild-type female C57BLl6J. The back-crossing of p47phox knockout gene into 
C57BLl6J were finally stopped by 8th generations. The p47phox heterozygote male and 
female mating was then carried out to obtain p47phox knockout mice (Figure 2.3). The 
genotypes of all mice were verified by genotyping (chapter 2.5). 
Figure 2.3: Representative gel image of identification of mice genotypes. 
A. 
B. 
500bp 
300bp 
1200p 
Lane: 1 2 3 4 5 6 7 
The genotypes of mice from the p47phOX heterozygote mating were verified by PCR-based 
genotyping. Lanes 1, 2 and 7 are p47phox heterozygote mice, showing both 400bp and 
1200bp bands; Lane 3, 4, 8 and 9 are wild-type mice, showing 400bp band only; Lane 5, 6 
and 10 are p47phOX knockout mice, showing 1200bp band only. 
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Figure 2.4: Diagrammatic description of back-crossing. 
" V) .. ' - ". ·'VJ.·· - ·, L~ /' ~ ~ .. / . ;,,'~ 
. '~~~::'J>'.p:) ~~~~::~J>"(') 
,~ ,~ 
~~ X ,..""0' KO - ~ ~ - p47'"~ KO 
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• .. ~ ~ ~ ~ X ~~ 
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• .. 
.. .. 
.N2 
~~ ~~ ~ ~ ~ ~ X ~~ 
female male female male wild.type C57JBI6 
.N3 female 
.N8 
• ... 
.. .. 
~~ ~~ ~ ~ X ~ ~ 
female male female male 
• + .. .. .. .. .. 
~~ ~~ ~ ~ ~ ~ ~~ ~~ 
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2.7 Cell Culture 
2.7.1 Isolation of Coronary Microvascular Endothelial Cells from Wildtype and 
p47phOX Knockout Mouse Hearts 
8- to 1 O-week-old male mice were used to isolate coronary microvascular endothelial cells 
(CMEC), and 6 mouse hearts were used for each CMEC preparation. The whole procedures 
were performed based on the technique described previously with slight modification (Li et 
aI., 2001).Tools and reagents used in procedures were all sterilised by 70% (v/v) ethanol 
immersion or autoclaving or filtration (O.2f.lm filters) as appropriate. 
Mice were killed by cervical dislocation and the bodies were briefly sprayed with 70% (v/v) 
ethanol followed by opening chest with scissors. Exposed hearts were removed with 
forceps and immediately immersed in ice-cold calcium-free phosphate buffered saline (PBS, 
Sigma). In the following steps, all procedures were carried out in the sterilised air-flowed 
tissue culture cabinet. Hearts were briefly dipped into 70% Ethanol to devitalise epicardial 
mesothelial cells, and re-immersed in ice-cold calcium-free PBS. Atria and valves were 
excised and discarded, and the ventricular cavities were opened and washed carefully with 
calcium-free PBS to get rid of blood. The ventricular tissue was then placed in a 100mm 
petri dish with PBS and cut into 1-2mm3 pieces using scissors. Minced tissue pieces were 
transferred into a 50ml centrifuge tube containing 25ml calcium-free PBS solution using a 
pre-wet 10ml pipette. The sedimentation of tissues naturally occurred in a few seconds. If 
not, the tissues were centrifuged at 25 x g for 3 minutes. The supernatant was discarded. 
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Tissue pellet was first digested at 37°C in 8ml pre-warmed 1 mg/ml collagenase type II 
(Lome Laboratories), dissolved in Hank's Buffered Salt Solution (HBSS, Sigma) 
supplemented with 2mg/ml glucose, 2.5mg/ml taurine, 0.1 % bovine serum albumin (BSA) 
and lAmM MgCJz. During the time, shearing suspension was performed by thoroughly 
pipetting 10 times every 2 minutes using a 10ml pipette. Eight minutes later, the 
supernatant containing cardiac myocytes was removed and transferred into a new tube with 
Iml fetal bovine serum (FBS, Invitrogen) to stop digestion. The pellet was further digested 
in collagenase digestion buffer with identical procedures as mentioned above. 
After a total of 4 times collagenase digestion, the remaining tissue pellet was continuously 
digested in 8ml pre-warmed 0.5mg/ml trypsin (Sigma) in modified HBSS containing 
2mglml glucose, 111g/ml Deoxyribonuclease (DNase) type II (Sigma) and O.lmM EDTA. 
The digestion was incubated at 37°C water bath for 6 minutes with 10 times thoroughly 
pipetting suspension every 2 minutes. At the end of this period, the supernatant was 
carefully transferred into a 15ml Falcon tube containing Iml FBS. After 3 minutes 
centrifuge at 25 x g, the supernatant was separated from the pellet (tissue debris and 
remaining myocytes) and centrifuged at 120 x g (4°C) for 7 minutes to sediment endothelial 
cells. The pellet of endothelial cells was then resuspended in Iml Dulbeco's Modified 
Eagle low glucose medium medium with 10% FBS and kept on ice. A further four times of 
6 minutes digestion period were required to isolate endothelial cells from remaining of 
tissue pellet. Finally, all endothelial cells were pooled together and seeded on a 1 % gelatin-
coated T25 flask. Cells were cultured at 37°C with 5% CO2• Two hours later, the medium 
containing debris and non-attached cells was replaced with complete CMEC growth 
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medium (Chapter 2.7.2). After incubation for 24 hours, cells were washed twice with pre-
warmed PBS and cultured in fresh CMEC medium. 
2.7.2 Primary Cells and Cell lines 
SVEC4-10 cells obtained from American Type Culture Collection is a mouse endothelial 
cell line derived by simian virus 40 transformation of endothelial cells from axillary lymph 
node vessels. Cells were cultured using Dulbeco's Modified Eagle high glucose medium 
(Sigma) supplemented with 10% heating-inactivated FBS (Invitrogen), 2mM L-glutamine 
(Sigma), 100units/mi penicillin and 1 OO~g/ml streptomycin (Sigma). SVEC4-10 cells from 
passage 5-15 were used for experiments. 
Wildtype and p47phOX knockout coronary microvascular endothelial cells (CMEC) isolated 
from mouse hearts (Chapter 2.7.1) were cultured in Dulbeco's Modified Eagle low glucose 
medium supplemented with 10% heating-inactivated FBS (Invitrogen), IOOunits/ml 
penicillin and 1 OO~g/ml streptomycin (Sigma), 2mM L-glutamine (Sigma), 50~g/ml 
endothelial cell growth supplement (Sigma), IOng/ml mouse epidermal growth factor (EGF, 
Sigma), 1 ~g/ml ascorbic acid (Sigma), I ~g/ml hydrocortisone (Sigma), 0.5ng/ml mouse 
vascular endothelial growth factor (VEGF, Sigma) and IOng/ml mouse insulin-like growth 
factor 1 (IGF-l, Sigma). Cells at passage 2 were used for experiments. 
Primary human lung microvascular endothelial cells at passage 3 were obtained from 
Lonza, UK. Cells were cultured in EGM-2-MV meidum supplimented with 5% FBS, 
human EGF, hydrocortisone, VEGF, GA-IOOO (gentamicin and amphotericin), human 
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FGF-B, R3-IGF-I and ascorbic acid (all provided in Clonetics EGM-2-MV medium Kit, 
Lonza). Cells at passage 6-7 were used for experiments. 
Nox2/p22Phox-reconstituted COS7phox cells were a kind gift provided by Professor Mary C. 
Dinauer (the Indiana University Medical Centre, USA). COS7 cells are a cell line derived 
from kidney cells of the African green monkey with a version of the SV40 genome that 
produce large T antigen but has a defect in genomic replication. As COS7 cells do not 
express Nox2, p22phOX, p40PhOX, p47phox and p67phoX, this cell type is a good cell model to 
study NADPH oxidase and Profeesor Dinauer's group has previously established this 
COS7phOX cells stably transfected with Nox2 and p22phox (Yu et aI., 1997). Nox2/p22phox_ 
reconstituted COS7phox cells were cultured in Dulbecoo's Modified Eagle low glucose 
medium (Sigma) plus 10% heat-inactivated FBS (Invitrogen), 2mM L-glutamine (Sigma), 
100units/ml penicillin, 100).lglml streptomycin (Sigma), O.Smg/ml G41S (Invitrogen) and 
1 Jlglml puromycin (Calbiochem) (Price et aI., 2002). 
2.7.3 Thawing Cells 
Cells preserved in liquid nitrogen tank were warmed up in 37°C water bath until observing 
a small block of ice in a cryotube. Cells were placed in a class II tissue culture cabinet and 
then transferred to a 14ml Falcon tube prefilled with 8ml phosphate buffered saline (PBS, 
Sigma). Cells were centrifuged down at 150 x g for 5min. After aspirating supernatant, cell 
pellet was thoroughly resuspended in 1 ml complete cell culture medium, and transferred 
into a cap-vented T75 flask containing 9ml complete cell culture medium. Cells were 
cultured in an incubator maintained at 37°C and 5% C02, until 90% confluence. 
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2.7.4 Passaging Cells 
On reaching about 90-95% confluence, culture medium was removed and cells were 
washed with 8ml PBS once. 3ml of Trypsin (0.5g/l)-EDTA (0.2g1l, Sigma) was added to 
coat the T75 flask (for T25 flask: using Iml of Trypsin-EDT A) and incubated at 37°C for 1-
2 minutes. The detached cells by trypinisation were immediately mixed with 5ml of 10% 
FBS cell culture medium (for T25 flask: using 2ml of 10% FBS cell culture medium) to 
neutralise the activity of trypsin. Cell suspension from the flask was transferred into a 
centrifuge tube and spun at 150 x g for 5 minutes. Cell pellet was resuspended in an 
appropriate volume of complete cell culture medium. A small volume of the cell suspension 
was taken to determine cell number and viability. 
2.7.5 Cell Counting and Viability 
In order to determine the cell number and viability, cells were counted on a 
haemocytometer with trypan blue, which is a negatively charged dye and does not interact 
with cell unless the membrane is damaged. A 20J..ll aliquot of cell suspension was mixed 
with 0.4% trypan blue (Sigma) at 1: 1 ratio. After 2 minute, diluted cells were then loaded 
onto a haemocytometer counting chamber with cover slip on top, and observed under a 
Zeiss light microscope at 200x magnification. Dead or dying cells were identified by their 
uptake of the blue dye. Dead and total cells in each 4x4, 1I25mm2 quadrant were counted, 
and the average number was taken from at least four out of nine quadrants. The cell 
viability was detemined by the percentage of dead cells in total cell counting. The total cell 
number is calculated according to equation: 
Total cell number= average cell number in each quandrant x 2 xl 04 X total cell volume 
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2.7.6 Freezing Cells 
Cells can be frozen and kept in liquid nitrogen for long-time storage. To freeze cells, 
freezing mixture was firstly prepared to make 20% DMSO/FBS by adding one volume of 
sterlised DMSO into four volumes of FBS. After thorough mixing, the freezing mixture 
was cooled on ice for at least 20 minutes (No more than 2 hours) before use. Cultured cells 
were trypinised and counted as described in Chapter 2.7.4 and Chpater 2.7.5. 0.5ml 
(containing 2 x 106 cells) of cell suspension in 10% FBS culture medium was transferred 
into a 2ml cryovial tube, and then mixed with an equal volume of pre-cooled 20% 
DMSOIFBS drop by drop using Iml pipette (keep on shaking tube while adding freezing 
mixture). Once cells were well mixed with freezing mixture, the cryovial was immediately 
transferred to a cryo-freezing container with isopropanol standing at room temperature and 
immediately placed at -80°C. As the temperature of isopropanol can be slowly decreased at 
the rate of 1°C in 1 minute, this property can prevent cells being damged by rapid 
temperture drop. The day after, the frozen cells were removed and stocked in the liquid 
nitrogen cell tank. 
2.8 Acute TN Fa Treatment 
To investigate TNFa-induced ROS production in endothelial cells, 2 x 106 of SVEC4-1 0 
cells were cultured with 4ml complete cell culture medium for 16 hours to allow cells to 
attach onto a 100mm dish. Cells wre then exposed to 100U/ml recombinant mouse TNFa 
(Roche applied system) by directly adding 4~1 of I OOU/~l mouse TNFa into culture 
medium with gentle orbital shaking. After 30 minutes incubation at 37°C, cells were 
washed in PBS twice and then immediately frozen at -80°C for at least 1 hour. Frozen cells 
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were harvested by adding 100f.l1 of lucigenin buffer (HBSS with 1.8mM CaCh and 0.8mM 
MgCh), MOPS buffer (20mM MOPS-KOH pH7.4, 100mM KCI, 3mM NaCI , 3.5mM 
MgCh, ImM EGTA, 250mM sucrose, 50mM sodium fluoride, ImM sodium orthovanadate, 
ImM sodium pyrophosphate and protease inhibitor cocktail I :500 dilution), or lysis buffer 
(50mM Tris-HCI pH7.4, 130mM NaCI, 2mM EDTA, 0.1% Triton X-IOO, 50mM sodium 
fluoride, ImM sodium orthovanadate, ImM sodium pyrophosphate and protease inhibitor 
cocktail I :500 dilution) and scraping into a 1.5ml eppendorf tube. Cells were then lysed by 
two pulses of 15 seconds sonication on ice using VC130PB ultrasonic processor at half of 
maximal amplitude. Cell homogenates were then used for lucigenin-chemiluminescence, 
membrane fractionation, or immunoblotting. 
For other prim any cell or cell lines, COS7phox cells and human lung endothelial cells were 
stimulated with 100U/ml recombinant human TNFa (Roche applied system) for 30 minutes, 
and wildtype and p47phox knockout coronary micovascular endothelial cells were stimulated 
with 100U/ml recombinant mouse TNFa for 30 minutes. 
2.9 Bradford Assay 
The protein Bradford assay was performed to determine total protein concentration. Briefly, 
a 1:5 dilution of the Bio-Rad protein assay dye was prepared by mixing with de ionised 
water in a total volume of Iml. 2f.l1 of cell homogenate was then added to the mixture and 
throughly mixed. The absorbance of each sample was measured at 595nm wavelength 
using a spectrophotometer (Perkin Elmer MBA 2000). In Comparison with a protein 
standard curve graphed by a known concentration of bovine serum albumin (BSA), protein 
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concentrations corresponding to each sample were then determined from their absorbance 
values. 
2.10 Measurement ofROS Production 
2.10.1 Lucigenin-enhanced chemiluminescence 
The detection of TNFa-induced ROS production in endothelial cells was assessed by 
lucigenin-enhanced chemiluminescence. Lucigenin reacts with superoxide forming a 
dioxetane that emits light when it decays. The emitted light was detected using a 96-well 
microplate luminometer (BMG Lumistar, Germany). The method used for the assay has 
been well established previously (Li et aI., 2007). Generally, cells after acute TNFa 
stimulation were homogenised as described in Chapter 2.8. The appropriate volume of cell 
extract containing 251lg protein was added to each well and the volume was made up to 140 
III with lucigenin buffer (Hank's balanced salt solution, 1.8mM CaCh and 0.8mM MgCh). 
Prior to starting the assay, ImM ofNADPH solution and 25J.1M of lucigenin solution were 
made using lucigenin buffer. To each well, 20111 of NADPH solution was added, and the 
96-well plate was immediately placed in the luminometer to allow the auto-dispenser to add 
40111 of lucigenin solution. The total reaction volume was 200lli with final concentration of 
51lM lucignin and 100llM NADPH. Measurments were taken at 37°C every 3 seconds per 
well and a total of20 cycles reading was recorded. 
Enzymatic sources of superoxide in cells were determined by preincubating 251lg cell 
extract in each well with following inhibitors at the the indicated final concentration: 20llM 
diphenyleneiodonium (DPI, flavoprotein inhibitor, Sigma), 10mM Tiron (02' scavenger, 
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Sigma), 100JlM N-nitro-L-arginine methyl ester (L-NAME, NOS inhibitor, Sigma), SOJlM 
rotenone (mitochondrial complex inhibitor, Sigma) and 100JlM oxypurinol (xanthine 
oxidase inhibitor, Sigma). 10 minutes later, lucigenin-chemiluminescence assay was 
performed as described above (Li et aI., 2007). 
2.10.2 Detection ofIntracellular ROS Production 
ROS generation in intact cells was detected using the 2, 7-dichlorofluorescein (DCF) assay. 
Chloromethyl-2, 7-dichlorofluorescein diacetate (CM-H2DCFDA), a non-fluorescent dye 
that is able to cross the plasma membrane is cleaved by intracellular esterases to give an 
ionic form that can not cross the plasma membrane. This product is then oxidised by ROS 
to give DCF which, when excited at 480nm, fluoresces at S20nm. Cells at 80% confluence 
per well in a 4-well chamber slide were incubated with S~ CM-H2DCFDA (Invitrogen) 
in HBSS buffer for 10 minutes. The cells were then incubated at 37°C for 30 minutes with 
or without 100U/ml TNFa treatment. All work with CM-H2DCFDA was carried out in the 
dark. At the end of the incubation period, cells were washed three times in cold HBSS and 
immediately observed under a flurorescent microscope (Olympus BX61, UK) using the 
488nm excitation line and SIS/30 bandpass emission filter. Ten images (200x 
magnification) of each well were randomly taken, and the fluorescent densities of at least 
five images for each condition were quantified using Digital Pixel Simple PCI sofeware. 
2.11 Cellular membrane fractionation 
Isolation of membrane fraction from cell homogenate was carried out as described 
previously (Li et aI., 200S). After acute TNFa treatment (detail in Chpater 2.8), cells were 
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detached by scraping and harvested in 300~1 MOPS Buffer (20mM MOPS-KOH pH 7.4, 
100mM KCI, 3mM NaCI , 3.5mM MgClz, ImM EGTA and 250mM sucrose) containing 
50mM sodium fluoride, ImM sodium orthovanadate, ImM sodium pyrophosphate and 
protease inhibitor cocktail (1 :500 dilution, Sigma). Cells were homogenised by sonication 
as described in chapter 2.8 and centrifuged at 200 x g in a pre-chilled (4°C) microcentrifuge 
for 10min. After centrifugation, supernatant was transferred into a 1.5ml Eppendorf tube 
and protein concentration was determined by Bradford assasy. Supernatant was further 
spun at 100,000 x g. In prior to ultracentrifugation, the paired samples were adjusted to the 
equal mass using an accurate weighting balance. 60 minutes later, the supernatant (cytosol) 
was transferred to another tube, and membrane pellet was resuspended in an equal volume 
of cytosol supernatant using MOPS buffer. Finally, the equal volume of cytosol and 
membrane for each sample was loaded for NADPH-dependent ROS analysis. All 
procedures were carried out on ice or at 4°C. 
2.12 Gene Transfection 
To understand the effect of p47Phox mutants on acute TNFa-induced NADPH oxidase 
activation, mutated plasm ids were transfected into SVEC4-10 cell line and chanllaged with 
TNFa. PEl (polyethylenimine linear MW=25,000), obtained from Polysciences Inc, was 
used for gene transfection. PEl, a cationic polymer, is able to condense DNA into positively 
charged particles, which bind to anionic cell surface and are brought into the cell via 
endocytosis. This reagent has been widely used for gene transfection of different cell types 
(Bischof et al., 1999; Florea et al., 2002; Lu et al., 2006; Werth et aI., 2006), including 
endothelial cells (Zaric et al., 2004). PEl stock was made at concentration of Img/ml in 
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H20 , ali quoted in 1.5ml eppondorf tube, and stored at -20°C. As PEl is not fully dissolved 
at room temperature in the concentration of I mg/ml, the PEl solution was heated at 50°C 
with agitation for hours until no crystal PEl was observed. 
The day before transfection, 1.2 x 106 cells (60% confluence) were seeded into 100mm 
dishes and cultured for 16 hours. The transfection medium was prepared by mixing 6~g of 
DNA plasmid with 40~1 of Imglml PEl in a total volume of 400~1 serum-free DMEM and 
kept for 15 minutes at room temperature. During the time, cells were washed once with 
serum-free medium and 3ml of serum-free medium was then placed into each dish. After 
the addition of transfection mix, cells were incubated at 37°C for 4 hours, which was 
followed by adding 3ml DMEM supplemented with 20% FBS. The day after, the medium 
was replaced with 5ml 10% FBS DMEM medium. 48 hours after transfection, cells were 
treated with 100U/ml TNFa for 30 minutes, washed in ice-cold PBS twice, and frozen at -
800C for further analysis. When tranfection was performed using different culture dishes or 
plates, the amounts of PEl and DNA used for transfection were scaled up and down 
according to different cell culture surface areas but with same PEl/DNA ratio. 
2.13 Western Blot 
Cell homogenates were prepared by sonication as previously described (Chpater 2.8). 
Protein concentration of each sample was determined by Bradford assay. Loading samples 
with equal protein concentration were finally prepared by adding 6x sample buffer, 
followed by boiling at 95°C for 5 minutes. Mini-Gels were prepared and run using the Bio-
Rad Mini-protean IITM (Bio-Rad, UK) apparatus according to the manufacturer's 
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instructions. A resolving gel of 10% acrylamide (Fisher Scientific) overlayed with a 
stacking gel of 5% acrylamide was used. Samples were loaded at 25)lg protein per well, 
and the first well loaded with a rainbow protein molecular marker (Lonza). The gel was run 
at 90V for 30 minutes and then 120V for about 90 minutes in Ix SDS running buffer until 
the loading dye was near the end of the resolving gel. The gel was then taken through 
Western blot analysis. 
The resolved proteins in the gel were blotted onto a Millipore Immobilon-P Polyvinylidene 
Difluoride (PVDF) transfer membrane (Sigma) using a Bio-Rad Semi-Dry Transfer Cell 
(Bio-Rad, UK). Transfer 'sandwich' was prepared by four pieces of filter paper (Whatman, 
UK), one set of rsolving gel, one piece of transfer membrane and four pieces of filter paper 
(from top to bottom). Before making 'sandwich', filter paper was immerged with transfer 
buffer for 15 minutes, and transfer membrane was pre-wet by absolute methanol for I 
minute, followed by brief tansfer buffer wash. The semi-dry transfer was run at constant 
15V for 50 minutes to I hour. The membrane was then briefly washed in PBS and blocked 
in 5% non-fat milk/Tris-buffered saline-O.I % Tween 20 (TBST) with orbital shaking at 
room temperature. One hour later, the membrane was probed at 4°C with primary antibody 
diluted at optimal concentration (Table 2.7) in 2.5% non-fat milklPBS. After overnight 
shaking, the membrane was washed in PBS for 3 times (10 minutes each time), and 
subsequently probed with horseradish peroxidise (HRP)-conjugated secondary antibody 
raised against mouse, rabbit, or goat antibodies for 1-2 hours at room temperature. With 
another 3 times PBS wash (10 minutes each time), the membrane was exposed to Enhanced 
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chemiluminescence Plus Reagent according to the manufacturer's instructions (GE 
Healthcare), and directly detected using a BioSpectrum AC Imaging System (UVP, UK). 
Recipes for Buffers 
4x Tris.CIISDS (pH 6.8, 500ml): 30g Tris-base, 2g SDS, pH to 6.8 with HCI 
4x Tris.CIISDS (pH 8.8, 500ml): 90g Tris-base, 2g SDS, pH to 8.8 with HCI 
6x Sample Buffer (lOml): 7ml 4x Tris.CI/SDS (PH 6.8), 30% Glycerol, 1 g SDS, 0.93g 
DTT, l.2mg bromphenol blue 
lOx Running Buffer (llitre): 30.3g Tris-base, 242.6g Glycine and 109 SDS 
1x Transfer Buffer (1 litre): 3.03 Tris-base, 14.4g Glycine, 200m} methanol 
lOx TBS (1 litre): 30g Tris-base, 80g NaCl, 2g KCI, pH to 7.4 
lOx PBS (1 litre): 80g NaCl, 2g KCI, 14.4g Na2HP04, 2.4g KH2P04, pH t07.4 
Mini Gel Recipe 
10% Resolving Gel (4 mini-gels): 12m} H20, 6ml 4x Tris.CI/SDS (pH8.8), 6ml 40% 
acrylamide, 16~1 N,N,N',N' -tetramethylethylenediamine (TEMED), 160~1 10% 
ammonium persulfate 
5% Stacking Gel (4 mini-gels): 7.5ml H20, 3ml 4x Tris.Cl/SDS (pH6.8), 1.5ml 40% 
acrylamide, 16~1 TEMED and 160~1 10% ammonium persulfate 
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Table 2.7 List of antibodies used in Western blotting 
Antibodies Species Dilution Company 
p47phox Rabbit 1:1000 Santa Cruz 
p-ERK Mouse 1:500 Santa Cruz 
ERK Rabbit 1:2000 Santa Cruz 
p-p38 MAPK Rabbit 1:1000 Cell signaling 
p38 MAPK Rabbit 1 :1000 Santa Cruz 
p-JNK Mouse 1:1000 Cell signaling 
JNK Rabbit 1:1000 Santa Cruz 
Alpha-tubulin Mouse 1:5000 Sigma 
Anti-mouse IgG HRP Goat 1:4000 Sigma 
Anti-rabbit IgG HRP Goat 1:4000 Sigma 
2.14 Statistics 
A student's t-test or one-way ANOVA was performed to determine whether results were 
statistically significant. Data were expressed as means of at least three independent 
experiments with standard deviation. The value P<0.05 indicated a significant difference. 
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Chapter 3: Construction of p47phOX Mutant Plasmids by 
Site-Directed Mutagenesis 
3.1 Introduction 
The nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is a membrane-
associated enzyme complex, which can generate superoxide by passing one electron 
donated from reduced form of NADPH through the membrane and coupling it with 
molecular oxygen. So far, at least 7 isoforms of NADPH oxidase (Noxl-5, Duoxl and 
Duox2) have been discovered to be widely expressed in all different cell types, but their 
functional roles are still not clear (Bedard and Krause, 2007; Kawahara et aI., 2007; 
Nauseef, 2008). Endothelial cells express three isoforms of Nox: Nox 1, Nox2 and Nox4. 
However, Nox2 and Nox4 are present with high expression levels in endothelial cells (Li et 
aI., 2007). Though Nox2 is well known to playa central role in host denfense in phagocytes, 
endothelial Nox2-generated superoxide and its oxygen derivatives are involved in redox 
signalling pathways, the mechanisms of which are poorly understood. 
The phagocyte-type NADPH oxidase (Nox2) is a multicomponent enzyme, the activation 
of which requires assembly of cytosolic subunits p47phoX, p67phoX, p40Phox and Rac with 
membrane-bound flavocytochrome bS58, a heterodimer of gp91 phox and p22phox (Babior et aI., 
2002). In resting conditions, p47phox exists as a self-inhibitory formation in the cytosol. 
Under agonist stimulation, p47phox undergoes multiple serines phosphorylation at its C-
terminal end. This phosphorylated form of p47phox leads to a rapid conformational change 
itself and releases its functional domains to interact with other NADPH oxidase subunits 
(p40PhOX, p67phOX, and p22PhOX) (Babior, 2004). At least ten serines are capable of being 
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phosphorylated in p47phoX, including residues S303, S304, S315, S320, S328, S345, S348, 
S359, S370, and S379 (EI Benna et aI., 1994; El Benna et aI., 1996a; Faust et aI., 1995). 
Phosphorylation of serine residues 303, 304 plays an important role in disrupting 
intramolecular functional domain interaction, and allowing p47phox to interact with p22phox 
(lnanami et aI., 1998). Phosphorylated S328 has been found as an actin-binding site 
(Tamura et aI., 2006). Phosphorylation at p47phox S345 is essential for priming of neutrophil 
NADPH oxidase activation (Dang et aI., 2006). Phosphorylation of serine residues 359 and 
370 is recognised as a prior step for other p47phox serine phosphorylation (Johnson et aI., 
1998; Massenet et aI., 2005). Serine 379 phosphorylation is necessarily required for p47Phox 
membrane translocation (Faust et aI., 1995). Though critical roles of p47phox serine 
phosphorylation have been revealed, those discoveries are on the basis of studies in 
phagocyte and there is little evidence to show the regulatory mechanisms of p47phox serine 
phosphorylation in endothelial cells. As the functions of Nox2 are fundamentally different 
between these two cell types, it is possible that the regulatory roles of p47phox serine 
phosphorylation might not be as found in phagocytic cells. 
To investigate the roles of p47phox serine phosphorylation in endothelial NADPH oxidase 
activation, ten serines (S303, S304, S315, S320, S328, S345, S348, S359, S370, and S379) 
in p47phOX were mutated to alanines, which is a non-polar and unphosphorylated amino acid. 
The serine to alanine mutation was carried out using in vitro site-directed mutagenesis to 
change the genetic coden sequence of designated serine for that of alanine in p47phox cDNA, 
which was constructed in pcDNA3.1 vector plasmid. Therefore, the important roles of 
p47phOX serine phosphorylation in NADPH oxidase activation can be revealed when 
endothelial cells are transfected with p47PhOX mutated plasmids. 
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3.2 Results 
3.2.1 Mutagenesis Efficiency 
The p47PhOX mutant plasm ids were constructed using in vitro site-directed mutagenesis. To 
test mutagenesis efficiency provided by the kit, a set of control primers provided in the kit 
were used to recover the modified plasmid containing stop codons in the LacZ coding 
sequence, resulting in the generation of blue colonies when E. coli transformants are grown 
in presence of isopropyl - l -thio-~-D-galactopyranoside (TPTG) and 5-bromo-4-chloro-3-
indolyl -~-D-galactopyranoside (X-Gal). As shown in Figure 3.1, the mutagenes is efficiency 
by this method was around 90%. 
F· e 3 1· Examl·natl·on of mutation 19ur .. efficiency by site-directed 
mutagenesis. 
Modified LacZ coding sequence in pUC18 vector was restored by PCR-based site-directed 
mutagenesis. Presence of blue colonies indicated successful mutation. 
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3.2.2 Construction of p47pbOX Serines 303/304 to Alanines Mutant Plasmid 
Human p47phox cDNA was constructed in mammalian expression vector pcDNA3.1lzeo-. 
To create the serines 303/304 to alanines mutation, PCR-based site-directed mutagenesis 
was performed using oligonucleotide primer with point base changes. By changing 'T' for 
'G' in the primer (Figure 3.2A), the genetic codon for expression of serines 303 and 304 
were altered to that of alanines 303 and 304. The Eae I restriction digest site (CGGCCA) 
was simultaneously introduced by the nucleotide alterations. Therefore, digestion of parent 
and unmutated plasmids with Eae I showed eight DNA bands: 24bp, 57bp, 84bp, 273bp, 
499bp, 1435bp, 1442bp and 2513bp; whereas the successful p47phox mutated plasmid with 
Eae I digestion showed nine DNA bands: 24bp, 57bp, 84bp, llObp, 273bp, 499bp, 1435bp, 
1442bp and 2403bp. Ten DNA plasmids isolated from ten individual colony selections 
were screened by Eae I digestion to identify additional 110bp band. In Figure 3.2B, 110bp 
band was observed in selections 4, 5, 7, 8, 9 and 10, indicating those plasm ids were 
successful p47phox serines 303 and 304 to alanines mutant constructs. To confirm p47phox 
serines 303 and 304 to alanines (S303/304A) mutation, DNA plasmid was sequenced to 
verify the alteration of nucleotides. As shown in Figure 3.2C, the sequencing result of the 
selection 4 (Figure 3.2B) exhibited identical nucleotide sequence as the designed 
S303/304A primer. 
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Figure 3.2: p47phox serines 303/304 to alanines mutation. 
A. B. 
\ p47PhOX S303f304(A) mutant construct 
tlegative Poslive 
coltrol coltrol S303.304(A) Selection:1 -10 100bp 
t t t 'T 
.. 300bp 
.. 200bp 
.. 100bp 
/ ~ ~ 
p47phox eDNA I 0 
Eael ~ c. t 
P P R R S S IR N A 
5'-CCG CCC CGC AGG TCG TCC ATC CGC MC GCG-3 ' 
P P R R A A I R N A 
'dO 290 3:lO 
C C G e e C C G C A G G G e GG C C A T C C G C A A C G C G 5'-CCG CCC CGC AGG GCG GCC ATC CGC AAC GCG-3' 
t 
Eael 
S303/J04 (A) + + 
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Legend to Figure 3.2: 
The human p47PhOX serines(S) 303/304 to aJanines(A) mutation was performed by PCR-
based site-directed mutagenesis. PCR products were digested with Kpn I and then 
transformed into competent E.coli cells. The amplified plasmid from single colony was 
digested with Eae I to verify successful mutation. 
A). Diagrammatic description of site-directed mutagenesis of p47phox serines 303/304 to 
alanines mutation. The human p47phox cDNA was inserted in pcDNA3.llzeo- vector at 
Hind III and Xba I sites. By changing 'T' for 'G' (letters with red colour) in the primer, the 
expression of serines was altered to the expression of alanines. The creation of Eae I 
restriction digest site accompanied by the nucleotide alterations was used for mutant 
screening. The underline indicated the Eae I restriction digest site: CGGCCA. 
B). Mutant screening by restriction digest analysis. The successful p47phox serines 303/304 
to alanines mutation was verified by identifying additional 110bp band after Eae I digest. 
Negative control: parent plasmid without Eae I digestion; Positive control: parent plasmid 
with Eae I digestion; Selection 1-10: plasm ids from 10 individual colonies with Eae I 
digestion. 
C). Confirmation of mutation by sequencing. The DNA plasmid of selection 4 (Figure 3.2B) 
was used for sequencing. Arrows indicated the mutated nucleotides. 
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3.2.3 Construction of p47pbOX Serine 315 to Alanine Mutant Plasmid 
To create the serine 315 to alanine mutation, PCR-based site-directed mutagenesis was 
performed using oligonucleotide primer with point base changes. By changing 'T' for 'G' 
and 'G' for 'T' in the primer (Figure 3.3A), the genetic codon for expression of serine 315 
was altered to that of alanine. The Sac I restriction digest site (GAGCTC) was also 
introduced by 'G' to 'A' silent mutation (Figure 3.3A). Therefore, digestion of parent and 
unmutated plasmids with Sac I showed single 7327bp DNA band; whereas the successful 
p47phOX mutated plasmid with Sac I digestion showed dual DNA bands: 1087bp and 5240bp. 
Eight DNA plasmids isolated from eight individual colony selections were screened by Sac 
I digestion to identify additional 1087bp band. In Figure 3.3B, 1087bp band was observed 
in selections 1, 2, 4, 5 and 6, indicating those plasm ids were successful p47phox serine 315 
to alanine (S315A) mutant constructs. To confirm p47phox serine 315 to alanine mutation, 
DNA plasmid was sequenced to verify the alteration of nucleotides. As shown in Figure 
3.3C, the sequencing result of selection 1 (Figure 3.3B) exhibited identical nucleotide 
sequence as the designed S315A primer. 
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Figure 3.3: p47phox serine 315 to alanine mutation. 
A. 
I p47PhOX S315(A)- rll~ta~t con~ruct I 
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Legend to Figure 3.3: 
The human p47phOX serine 315 to alanine mutation was performed by PCR-based site-
directed mutagenesis. PCR products were digested with Kpn I and then transformed into 
competent E.coli cells. The amplified plasmid from single colony was digested with Sac I 
to verify successful mutation. 
A). Diagrammatic description of site-directed mutagenesis of p47phox serine 315 to alanine 
mutation. The human p47phox cDNA was inserted in pcDNA3.lIzeo- vector at Hind III and 
Xba I sites. By changing 'T' for 'G' and 'G' for 'T' in the primer, the expression of serine 
was altered to the expression of alanine. The addition of Sac I restriction digest site 
introduced by the 'G' to 'A' silent mutation was applied for mutant screening. The 
underline indicated the Sac I restriction digest site: GAGCTC; Red letters indicated altered 
nucleotides. 
B). Mutant screening by restriction digest analysis. The successful p47phox serine 315 to 
alanine mutation was verified by identifying additional 1087bp band after Sac I digest. 
Negative control: parent plasmid without Sac I digestion; Positive control: parent plasmid 
with Sac I digestion; Selection 1-8: plasmids from 8 individual colonies with Sac I 
digestion. 
C). Confirmation of mutation by sequencing. The DNA plasmid of selection 1 (Figure 3.3B) 
was used for sequencing. Arrows indicated the mutated nucIeotides. 
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3.2.4 Construction of p47phox Serine 320 to Alanine Mutant Plasmid 
To create the serine 320 to alanine mutation, PCR-based site-directed mutagenesis was 
performed using oligonucleotide primer with point base changes. By changing 'AG' for 
'GC' in the primer (Figure 3.4), the genetic codon for expression of serine 320 was altered 
to that of alanine. The Nhe I restriction digest site (GCTAGC) was also introduced by 'c' 
to 'A' silent mutation (Figure 3.4A). Therefore, digestion of parent and unmutated plasmids 
with Nhe I showed two DNA bands: 1263bp and 5064bp; whereas the successful p47phox 
mutated plasmid with Nhe I digestion showed three DNA bands: 224bp, 1019bp and 
5064bp. Eight DNA plasmids isolated from eight individual colony selections were 
screened by Nhe I digestion to identify additional 224bp band. In Figure 3.4B, 224bp band 
was observed in selections 2, 4, 5, 6, 7 and 8, indicating those plasm ids were successful 
p47phOX serine 320 to alanine (S320A) mutant constructs. To confirm p47phox serine 320 to 
alanine mutation, DNA plasmid was sequenced to verify the alteration of nucleotides. As 
shown in Figure 3.4C, the sequencing result of selection 2 (Figure 3.4B) exhibited identical 
nucleotide sequence as the designed S320A primer. 
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Figure 3.4: p47PhOX serine 320 to alanine mutation. 
A. 
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/ ~ 
p47phox eDNA I 01-----1 
Nhel 
t 
R S R K R L S Q 0 A Y 
5'-CGG TCG CGG AAG CGC eTC AGC CAG GAC GCC TAT CG-3' 
R S R K R L A Q 0 AY 
5'-CGG TCG CGG AAG CGG CT A GCC CAG GAC GCC TAT CG-3' 
t S320(A) 
Nhel 
B. 
5kb 
1kb 
c. 
Positive 
lIegative cORrol 
1kb cORrol 
ladder 
S320(A) Selection:1 -8 100bp ladder 
1.2kb 
300bp 
100kb 
~~ 
L 
C GG T C G C GG AA G C GG C T A G CCC A GG AC G CC i A i C G 
#+ 
98 
Legend to Figure 3.4: 
The human p47phox serine 320 to alanine mutation was performed by PCR-based site-
directed mutagenesis. PCR products were digested with Kpn I and then transformed into 
competent E.coli cells. The amplified plasmid from single colony was digested with Nhe I 
to verify successful mutation. 
A). Diagrammatic description of site-directed mutagenesis of p47phox serine 320 to alanine 
mutation. The human p47phox cDNA was inserted in pcDNA3.lIzeo- vector at Hind III and 
Xba I sites. By changing 'AG' for 'GC' in the primer, the expression of serine was altered 
to the expression of alanine. The addition of Nhe I restriction digest site introduced by the 
'C' to 'A' silent mutation was applied for mutant screening. The underline indicated the 
Nhe I restriction digest site: GCTAGC. Red letters indicated altered nucleotides. 
B). Mutant screening by restriction digest analysis. The successful p47phox serine 320 to 
alanine mutation was verified by identifying additional 224bp band after Nhe I digest. 
Negative control: parent plasmid without Nhe I digestion; Positive control: parent plasmid 
with Nhe I digestion; Selection 1-8: plasmids from 8 individual colonies with Nhe I 
digestion. 
C). Confirmation of mutation by sequencing. The DNA plasmid of selection 2 (Figure 3.4B) 
was used for sequencing. Arrows indicated the mutated nucleotides. 
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3.2.5 Construction of p47pbOX Serine 328 to Alanine Mutant Plasmid 
To create the serine 328 to alanine mutation, PCR-based site-directed mutagenesis was 
performed using oligonucleotide primer with point base changes. 8y changing 'AG' for 
'GC' in the primer (Figure 3.5A), the genetic codon for expression of serine 328 was 
altered to that of alanine. The BsiW I restriction digest site (CGTACG) was also introduced 
by 'c' to 'A' silent mutation (Figure 3.5A). Therefore, there was no BsiW I digestion site 
for parent and unmutated plasmids; whereas the successful p47phox mutated plasmid with 
BsiW I digestion showed single linear 6327bp DNA band. Eight DNA plasm ids isolated 
from eight individual colony selections were screened by BsiW I digestion to identify single 
6327bp DNA band. In Figure 3.58, 6327bp linear DNA band was observed in selections 1, 
3, 4, 5, 6 and 7, indicating those plasmids were successful p47phox serine 328 to alanine 
(S328A) mutant constructs. To confirm p47phox serine 328 to alanine mutation, DNA 
plasmid was sequenced to verify the alteration ofnucleotides. As shown in Figure 3.5C, the 
sequencing result of selection 1 (Figure 3.58) exhibited identical nucleotide sequence as 
designed S328A primer. 
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Figure 3.5: p47phOX serine 328 to alanine mutation. 
A. 
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Legend to Figure 3.5: 
The human p47phOX serine 328 to alanine mutation was performed by PCR-based site-
directed mutagenesis. PCR products were digested with Kpn I and then transformed into 
competent E.coli cells. The amplified plasmid from single colony was digested with BsiWI 
to verify successful mutation. 
A). Diagrammatic description of site-directed mutagenesis of p47phox serine 328 to alanine 
mutation. The human p47phox cDNA was inserted in pcDNA3.l/zeo- vector at Hind III and 
Xba I sites. By changing 'AG' for 'GC' in the primer, the expression of serine was altered 
to the expression of alanine. The addition of BsiW I restriction digest site introduced by the 
'C' to 'A' silent mutation was applied for mutant screening. The underline indicated the 
BsiW I restriction digest site: CGTACG. Red letters indicated altered nucleotides. 
B). Mutant screening by restriction digest analysis. The successful p47phox serine 328 to 
alanine mutation was verified by identifying single 6327bp band after BsiW I digest. 
Negative control: parent plasmid without BsiW I digestion; Positive control: parent plasmid 
with BsiW I digestion; Selection 1-8: plasm ids from 8 individual colonies with BsiW I 
digestion. 
C). Confirmation of mutation by sequencing. The DNA plasmid of selection I (Figure 3.5B) 
was used for sequencing. Arrows indicated the mutated nucleotides. 
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3.2.6 Construction of p47pbOX Serine 345 to Alanine Mutant Plasmid 
To create the serine 345 to alanine mutation, PCR-based site-directed mutagenesis was 
performed using oligonucleotide primer with point base changes. By changing 'AG' for 
'GC' in the primer (Figure 3.6A), the genetic codon for expression of serine 345 was 
altered to that of alanine. The Apa I restriction digest site (GGGCCC) was also introduced 
by 'A' to 'C' silent mutation (Figure 3.6A). Therefore, digestion of parent and unmutated 
plasm ids with Apa I showed single 6327bp DNA band; whereas the successful p47phox 
mutated plasmid with Apa I digestion showed two DNA bands: 1075bp and 5252bp. Eight 
DNA plasm ids isolated from eight individual colony selections were screened by Apa I 
digestion to identify additional 107 5bp band. In Figure 3.6B, 107 5bp band was observed in 
selections 2, 3, 4, 5 and 8, indicating those plasm ids were successful p47phol( serine 345 to 
alanine (S345A) mutant constructs. To confirm p47PhOX serine 345 to alanine mutation, 
DNA plasmid was sequenced to verify the alteration of nucleotides. As shown in Figure 
3.6C, the sequencing result of selection 2 (Figure 3.6B) exhibited identical nucleotide 
sequence as the designed S345A primer. 
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Figure 3.6: p47phOX serine 345 to alanine mutation. 
A. 
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Legend to Figure 3.6: 
The human p47PhOX serine 345 to alanine mutation was performed by PCR-based site-
directed mutagenesis. PCR products were digested with Kpn I and then transformed into 
competent E.coli cells. The amplified plasmid from single colony was digested with Apa I 
to verify successful mutation. 
A). Diagrammatic description of site-directed mutagenesis of p47phox serine 345 to alanine 
mutation. The human p47phox cDNA was inserted in pcDNA3.lIzeo- vector at Hind III and 
Xba I sites. By changing' AG' for 'GC' in the primer, the expression of serine was altered 
to the expression of alanine. The addition of Apa I restriction digest site introduced by the 
'A' to 'c' silent mutation was applied for mutant screening. The underline indicated the 
Apa I restriction digest site: GGGCCC. Red letters indicated altered nucleotides. 
B). Mutant screening by restriction digest analysis. The successful p47phox serine 345 to 
alanine mutation was verified by identifying additional 1075bp band after Apa I digest. 
Negative control: parent plasmid without Apa I digestion; Positive control: parent plasmid 
with Apa I digestion; Selection 1-8: plasmids from 8 individual colonies with Apa I 
digestion. 
C). Confirmation of mutation by sequencing. The DNA plasmid of selection 2 (Figure 3.6B) 
was used for sequencing. Arrows indicated the mutated nucleotides. 
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3.2.7 Construction of p47pbOX Serine 348 to Alanine Mutant Plasmid 
To create the serine 348 to alanine mutation, PCR-based site-directed mutagenesis was 
performed using oligonucleotide primer with point base changes. By changing 'AG' for 
'GC' in the primer (Figure 3.7A), the genetic codon for expression of serine 348 was 
altered to that of alanine. The natural Sma I restriction digest site (GGGCCC) was also 
abolished by 'G' to 'A' silent mutation (Figure 3.7A). Therefore, digestion of parent and 
unmutated plasmids with Sma I showed four DNA bands: 196bp, 1063bp, 1392bp and 
3676bp; whereas the successful p47phox mutated plasmid with Sma I digestion showed three 
DNA bands: 196bp, 2455bp and 3676bp. Eight DNA plasmids isolated from individual 
colony selections were screened by Sma I digestion to identify 2455bp band. In Figure 3.7B, 
2455bp band was observed in selections 1, 2, 4, 5 and 6, indicating those plasm ids were 
successful p47PhOX serine 348 to alanine (S348A) mutant constructs. To confirm p47phox 
serine 348 to alanine mutation, DNA plasmid was sequenced to verify the alteration of 
nucleotides. As shown in Figure 3.7C, the sequencing result of selection 1 (Figure 3.7B) 
exhibited identical nucleotide sequence as the designed S348A primer. 
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Figure 3.7: p47phox serine 348 to alanine mutation. 
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Legend to Figure 3.7: 
The human p47PhOX serine 348 to alanine mutation was performed by PCR-based site-
directed mutagenesis. PCR products were digested with Kpn I and then transformed into 
competent E.coli cells. The amplified plasmid from single colony was digested with Sma I 
to verify successful mutation. 
A). Diagrammatic description of site-directed mutagenesis of p47phox serine 348 to alanine 
mutation. The human p47phox cDNA was inserted in pcDNA3.lIzeo- vector at Hind III and 
Xba I sites. By changing' AG' for 'GC' in the primer, the expression of serine was altered 
to the expression of alanine. The abolishment of Sma I restriction digest site simultaneously 
introduced by the 'G' to 'A' silent mutation was applied for mutant screening. The 
underline indicated the Sma I restriction digest site: CCCGGG. Red letters indicated altered 
nucleotides. 
B). Mutant screening by restriction digest analysis. The successful p47phox serine 348 to 
alanine mutation was verified by identifying 2455bp band after Sma I digest. Negative 
control: parent plasmid without Sma I digestion; Positive control: parent plasmid with Sma 
I digestion; Selection 1-8: plasmids from 8 individual colonies with Sma I digestion. 
C). Confirmation of mutation by sequencing. The DNA plasmid of selection 1 (Figure 3.7B) 
was used for sequencing. Arrows indicated the mutated nuc1eotides. 
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3.2.8 Construction of p47pbox Serine 359 to Alanine Mutant Plasmid 
To create the serine 359 to alanine mutation, PeR-based site-directed mutagenesis was 
performed using oligonucleotide primer with point base changes. By changing 'r for 'G' 
in the primer (Figure 3.8A), the genetic codon for expression of serine 359 was altered to 
that of alanine. The natural Ale I restriction digest site (AGCGCT) was also simultaneously 
abolished by the point mutation (Figure 3.8A). Therefore, digestion of parent and 
unmutated plasmids with Ale I showed two DNA bands: I023bp and 5304bp; whereas the 
successful p47phOX mutated plasmid with Ale I digestion showed single 6327bp DNA band. 
Ten DNA plasm ids isolated from individual colony selections were screened by Ale I 
digestion to identify single 6327bp band. In Figure 3.8B, 6327bp band was observed in 
selections 1,2,4,6, 7, 8,9 and 10, indicating those plasm ids were successful p47phox serine 
359 to alanine (S359A) mutant constructs. To confirm p47phox serine 359 to alanine 
mutation, DNA plasmid was sequenced to verify the alteration of nucleotides. As shown in 
Figure 3.8C, the sequencing result of selection 1 (Figure 3.8B) exhibited identical 
nucleotide sequence as the designed S359A primer. 
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Figure 3.8: p47phox serine 359 to alanine mutation. 
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Legend to Figure 3.8: 
The human p47phOX serine 359 to alanine mutation was performed by PCR-based site-
directed mutagenesis. PCR products were digested with Kpn I and then transformed into 
competent E.coli cells. The amplified plasmid from single colony was digested with Ale I to 
verify successful mutation. 
A). Diagrammatic description of site-directed mutagenesis of p47Phox serine 359 to alanine 
mutation. The human p47phox cDNA was inserted in pcDNA3.1/zeo- vector at Hind III and 
Xba I sites. By changing 'T' for 'G' in the primer, the expression of serine was altered to 
the expression of alanine. The natural Afe I restriction digest site (AGCGCT) was also 
simultaneously abolished by the single nucleotide alteration. The underline indicated the 
Aft I restriction digest site: AGCGCT. Red letters indicated altered nucleotides. 
B). Mutant screening by restriction digest analysis. The successful p47phox serine 359 to 
alanine mutation was verified by identifying single 6327bp band after Afe I digest. Negative 
control: parent plasmid without Ale I digestion; Positive control: parent plasmid with Afe I 
digestion; Selection 1-10: plasmids from 10 individual colonies with Afe I digestion. 
C). Confirmation of mutation by sequencing. The DNA plasmid of selection 1 (Figure 3.8B) 
was used for sequencing.The arrow indicated the mutated nucleotides. 
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3.2.9 Construction of p47pbOX Serine 370 to Alanine Mutant Plasmid 
To create the serine 370 to alanine mutation, PeR-based site-directed mutagenesis was 
performed using oligonucleotide primer with point base changes. By changing 'AG' for 
'GC' in the primer (Figure 3.9A), the genetic codon for expression of serine 370 was 
altered to that of alanine. The Nae I restriction digest site (GCCGGC) was also 
simultaneously introduced by the alternation of nucleotides (Figure 3.9A). Therefore, 
digestion of parent and unmutated plasmids with Nae I showed five DNA bands: 61 bp, 
114bp, 689bp, 1033bp and 4430bp; whereas the successful p47phox mutated plasmid with 
Nae I digestion showed six DNA bands: 18bp, 61bp, 114bp, 671bp, 1033bp and 4430bp. 
Three DNA plasmids isolated from individual colony selections were screened by Nae I 
digestion to identify additional 18bp band. In Figure 3.9B (left panel), 18bp band was 
observed in selections 2 and 3, indicating those plasmids were successful p47phox serine 370 
to alanine (S370A) mutant constructs. To confirm p47phox serine 370 to alanine mutation, 
the DNA plasmid was sequenced to verify the alteration of nucleotides. As shown in Figure 
3.9C, the sequencing result of selection 3 (Figure 3.9B) exhibited identical nucleotide 
sequence as the designed S370A primer. 
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Figure 3.9: p47phox serine 370 to alanine mutation. 
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Legend to Figure 3.9: 
The human p47phOX serine 370 to alanine mutation was performed by PCR-based site-
directed mutagenesis. PCR products were digested with Kpn I and then transformed into 
competent E.coli cells. The amplified plasmid from single colony was digested with Nae I 
to verify successful mutation. 
A). Diagrammatic description of site-directed mutagenesis of p47phOX serine 370 to alanine 
mutation. The human p47phox cDNA was inserted in pcDNA3.1/zeo- vector at Hind III and 
Xba I sites. By changing 'AG' for 'GC' in the primer, the expression of serine was altered 
to the expression of alanine. The addition of Nae I restriction digest site simultaneously 
introduced by point mutation was applied for mutant screening. The underline indicated the 
Nae I restriction digest site: GCCGGC. Red letters indicated altered nuc1eotides. 
B). Mutant screening by restriction digest analysis. The successful p47phox serine 370 to 
alanine mutation was verified by identifying additional 18bp band after Nae I digest. Left 
panel: DNA bands with long exposure time under UV; Right panel: DNA bands with short 
exposure time under UV; Positive control: parent plasmid with Nae I digestion. Selection 
1-3: plasm ids from 3 individual colonies with Nae I digestion. 
C). Confirmation of mutation by sequencing. The DNA plasmid of selection 3 (Figure 3.9B) 
was used for sequencing. Arrows indicated the mutated nuc1eotides. 
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3.2.10 Construction of p47pbOX Serine 379 to Alanine Mutant Plasmid 
To create the serine 379 to alanine mutation, PCR-based site-directed mutagenesis was 
performed using oligonucleotide primer with point base changes. By changing' AG' for 
'GC' in the primer (Figure 3.10A), the genetic codon for expression of serine 379 was 
altered to that of alanine. The natural Pst I restriction digest site (CTGCAG) was also 
simultaneously abolished by the point mutation (Figure 3.10A). Therefore, digestion of 
parent and un mutated plasm ids with Pst I showed five DNA bands: 13 7bp, 181 bp, 312bp, 
522bp and 5175bp; whereas the successful p47phox mutated plasmid with Pst I digestion 
showed four DNA bands: 181bp, 312bp, 522bp and 5312bp. Six DNA plasmids isolated 
from individual colony selections were screened by Pst I digestion. In Figure 3.1 OB, the 
disappeared 137bp band was in selections I, 2, 4 and 6, indicating those plasmids were 
successful p47phOX serine 379 to alanine (S379A) mutant constructs. To confirm p47phOX 
serine 379 to alanine mutation, DNA plasmid was sequenced to verify the alteration of 
nucleotides. As shown in Figure 3.lOC, the sequencing result of selection 1 (Figure 3.1 OB) 
exhibited identical nucleotide sequence as the designed S379A primer. 
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Figure 3.10: p47phOX serine 379 to alanine mutation. 
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Legend to Figure 3.10: 
The human p47phOX serine 379 to alanine mutation was performed by PCR-based site-
directed mutagenesis. PCR products were digested with Kpn I and then transformed into 
competent E.coli cells. The amplified plasmid from single colony was digested with Pst I 
to verify successful mutation. 
A). Diagrammatic description of site-directed mutagenesis of p47phox serine 379 to alanine 
mutation. The human p47phox eDNA was inserted in pcDNA3.lIzeo- vector at Hind III and 
Xha I sites. By changing 'AG' for 'GC' in the primer, the expression of serine was altered 
to the expression of alanine. The natural Pst I restriction digest site was also simultaneously 
abolished by the alteration of nucIeotides. The underline indicated the Pst I restriction 
digest site: CTGCAG. Red letters indicated altered nucIeotides. 
B). Mutant screening by restriction digest analysis. The successful p47phox serine 379 to 
alanine mutation was verified by identifying the disappeared 137bp band after Pst I digest. 
Negative control: parent plasmid without Pst I digestion; Positive control: parent plasmid 
with Pst I digestion; Selection 1-6: plasm ids from 6 individual colonies with Pst I digestion. 
C). Confirmation of mutation by sequencing. The DNA plasmid of selection 1 (Figure 
3.1 DB) was used for sequencing. Arrows indicated the mutated nucIeotides. 
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3.3 Discussion 
Phosphorylation is a wide and common biochemical reaction in many biological events and 
it is defined as the introduction of a phosphate group to a protein molecule, which may play 
an essential regulatory role in cellular processes. Although adding a phosphoryl to an R 
group of an amino acid might not trigger a strong conformational change, it can actually 
convert a nonpolar hydrophobic protein to a polar and hydrophilic molecule. In this way, 
the activation of many enzymes and receptors are strictly controlled by phosphorylation and 
dephosphorylation. Phosphorylation occurs at amino acids with hydroxyl group, where the 
link between amino acid and phosphate is established by dehydrolysis of their hydroxyl 
groups. In nature, phosphorylation at serine, threonine and tyrosine are most commonly 
observed. 
Multiple serines phosphorylation occurs in p47phox when NADPH oxidase is activated. To 
understand the role of individual p47PhOX serine phosphorylation in NADPH oxidase 
activation, replacement of serine for a non-phosphorylated amino acid is a good method to 
investigate the function of serine phosphorylation. The best candidate is alanine, which is 
uncharged amino acid and exhibits the most similar chemical structure as serine. 
The individual serine of p47PhOX was replaced by alanine usmg in vitro site-directed 
mutagenesis to change their genetic codon of serine for that of alanine in p47phox cDNA 
sequence, which was constructed in mammalian expression vector (pcDNA3.l). The 
technique of mutagenesis is on the basis of peR, using a mismatched primer to change the 
designated nucleotide(s). Sequencing is the best way to confirm the successful mutation 
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and check unexpected simultaneous nucleotide change during peR. However, it is 
relatively time-consuming and costly at the screening stage. Therefore, creation or 
abolishment of the restriction digest site was also designed in the primer by silent mutation, 
which is known as the nucleotide change in the genetic codon does not alter the expression 
of amino acid. By this technique, the successful mutation can be screened by identification 
of additional or less bands when the plasmid is digested by specific restriction enzyme. 
From my data shown in the chapter, ten serines of p47phox (S303/304, S315, S320, S328, 
S345, 5348, 5359, S370 and S379) were successfully mutated to alanines by in vitro site-
directed mutagenesis, and the introduction of restriction digest site by silent mutation 
provided an efficient method for mutant screening. 
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Chapter 4: Roles of p47PhOX Serine Phosphorylation in TNFa-
Induced Endothelial NADPH Oxidase Activation 
4.1 Introduction 
Endothelial cells generate reactive oxygen species (ROS) which are necessarily required to 
maintain cardiovascular homeostasis. ROS over-generation (oxidative stress) is believed to 
result in endothelial dysfunction, which has a close link to many cardiovascular diseases 
such as heart failure, cardiac hypertrophy, atherosclerosis and diabetes (Gao and Mann, 
2009; Harrison et aI., 2003a; Li et aI., 2002a; Li and Shah, 2003b). Though several 
enzymatic sources of ROS exist in endothelial cells, previous studies have suggested 
NADPH oxidase is the major ROS producer in response to various stimulators such as 
angiotensin II (Ang II) and tumor necrosis factor-alpha (TNFa) (Li et aI., 2002b; Li and 
Shah, 2003a). 
TNFa is one of TNF family of cytokines, exhibiting divergent biological functions in 
immune regulation, inflammation, differentiation, cell proliferation and apoptosis (Wajant 
et aI., 2003). TNFa is mainly produced by macrophages, and less expressed in lymphoid 
cells, endothelial cells, and fibroblasts (Korobowicz, 2006). TNFa primarily exists as a 
transmembrane protein arranged in stable homotrimers (Tang et aI., 1996). It can be 
released via proteolytic cleavage by the metalloprotease TNFa converting enzyme to form 
soluble homotrimeric cytokine (Black et aI., 1997). TNFa can bind with two receptors, 
TNF-Receptor 1 (TNFRl) and TNF-Receptor 2 (TNFR2). TNFRI is consitutively 
expressed in most tissues, whereas TNFR2 is typically found in endothelial cells and 
immune cells (Wajant et aI., 2003). Both recptors share similar extracellular domains 
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(Locksley et al., 2001), but their distinctive intracellular domains suggest that these two 
receptors link with different downstream cell signalling pathway (Korobowicz, 2006; 
MacEwan, 2002). 
TNFa-associated cardiovacular diseases, such as atherosclerosis (Bruunsgaard et al., 2000) 
and diabetes (Holstad and Sandler, 200 I; Spranger et al., 2003), have been identified. 
Though the molecular mechnisms are still not fully understood, recent studies strongly 
suggested TNFa-induced excessive ROS via NADPH oxidase is involved in the 
pathogenesis of endothelial dysfunction (Chen et al., 2003b; Jung et al., 2004; Nwariaku et 
al., 2004). Nox2, known as phagocyte-type NADPH oxidase, is also mainly expressed in 
endothelial cells. The intracellular ROS generated by Nox2 can be increased by TNFa 
treatment via p47phOX activation, which is a key step for Nox2 activation. This has been 
confirmed by the discovery that TNFa failed to increase ROS generation in p47phox-l-
coronary microvascular endothelial cells (Li et al., 2005). The kinase-dependent p47phox 
activation initiates with its C-terminal serine phosphorylation, which then releases p47phox 
functional domains to co-ordinate the interation between other cytosolic subunits and 
membrane-bound Nox2/p22phOX heterodimer. Phosphorylation of p47phox is mainly 
regulated by protein kinase C isoforms (PKC) (Fontayne et al., 2002), although other 
kinases including Src kinases (Touyz et al., 2003), protein kinase B (Akt) (Chen et al., 
2003a), mitogen-activated protein kinases (MAPKs) (El Benna et al., 1996b), and p21-
activated kinase (Martyn et al., 2005) also play a role depending on stimulus . TNFa-
induced p47phox serine phosphorylation is PKC-dependent in endothelial cells. Frey et al. 
have shown that TNFa-induced p47phox phosphorylation in lung vascular endothelial cells is 
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activated by an atypical PKC isoform, PKC-~ (Frey et aI., 2002). However, it is still 
unkown which p47phOX serine residue is phosphorylated and plays an important role in 
TNFa-induced Nox2-derived ROS production in endothelial cells. Therefore, TNFa-
induced crucial p47phox serine phosphorylation for Nox2 activation was verified by 
introducing different serine to alanine mutations among p47phox phosphorylation region 
(amino acid residues 300-380). 
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4.2 Results 
4.2.1 Acute TNFIl-Induced Endothelial ROS Production 
SVEC4-10 is an immortalised mouse endothelial cell line with simian ViruS 40 
transformation. To characterise the ROS production of this cell line in response to TNFa, 
the time course of acute TNFa stimulation in SVEC4-10 cells was carried out and ROS 
levels of different time points were examined using NADPH-dependent lucigenin 
chemiluminescence. As shown in Figure 4.1, 100V/ml TNFa was able to induce a 
significant increase in ROS production as early as 5 minutes. This rise in ROS production 
lasted until 30 minutes at which point there was a two-fold increase ROS production 
compared to control group (unstimulated cells). Though a slight drop of ROS production 
was observed after 30 minutes, TNFa-induced ROS incease was still significantly higher 
than control group, and the levels of ROS were relatively stable. Therefore, these results 
demonstrated that the S VEC4-1 0 cell line was a good cell model to study the mechanism of 
TNFa-induced endothelial ROS production, and the condition of 30 minutes TNFa 
(lOOV/ml) stimulation was applied for subsequent experiments. 
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Figure 4.1: Time course of acute TNFa-induced endothelial ROS 
production. 
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SVEC4-10 Cells at -80% confluence were treated with 100U/ml TNFa for various time 
points. Cells were then homogenised for ROS measurement by NADPH (1 OO~M)­
dependent lucigenin (5~)-chemiluminescence. Data were expressed as means (MLU 
represents mean light unit) ± standard deviation of three independent experiments. * 
p<0.05 and ** P<O.OI were obtained by comparing TNFa-stimulated cells to un-stimulated 
cells (control) with Dunnett's One-way ANOVA. 
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4.2.2 Enzymatic Sources of ROS in Response to TNFa Stimulation 
There are several main enzymatic sources of ROS in endothelial cells, including 
mitochondria, nitric oxide synthase, xanthine oxidase, cytochrome P450 and NADPH 
oxidase. To find out the major enzymatic source in response to TNFa stimulation in 
endothelial cells, an enzymatic inhibition assay was performed by using different specific 
enzymatic inhibitors. In Figure 4.2A, an NADPH-independent assay was carried out for the 
first 10 minutes and the ROS production was hardly detected. With the addition ofNADPH 
afterwards, a certain level of ROS was detected in the control cells and a significantly 
higher ROS production was detected in TNFa-treated cells over 30 minutes (Figure 4.28). 
This suggests that TNFa-induced activation of ROS production is NADPH-dependent in 
endothelial cells. When TNFa-treated cell homogenates were incubated with the inhibitors 
L-NAME (nitric oxide synthase inhibitor), Oxypurinol (xanthine oxidase inhibitor), or 
Rotenone (mitochondrial complex inhibitor), there were no significant effects on TNFa-
induced ROS production. However, a dramatic decrease in ROS production was observed 
in Tiron (superoxide scarvanger) and DPI (flavoprotein inhibitor) treatments (Figure 4.2C). 
As NADPH oxidase is a flavoprotein, the results strongly indicate that TNFa-induced ROS 
production is via activation ofNADPH oxidase in endothelial cells. 
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Figure 4.2: Analysis of enzymatic sources of ROS production in TNFa 
stimulated cell homogenates. 
A. 
400 NADPH 
1 
TNFa 
£: 
(I) 300 
-0 ~ 
Q. Control 
Cl 200 
E 
-::J 
-I 100 ~ 
0 
1 4 7 10 13 16 19 22 25 28 
Minutes 
B. 
400 
** £: 300 (I) 
-0 ~ 
Q. 200 Cl 
E 
-::J 100 -I ~ 
0 
Control TNFa 
c. 
400 
£: 300 
"4) 
-0 ~ 
~ 200 . . . . · .. 
E 
-
. .. 
::J · . 
..J 100 · . ~ · .. 
· .. 
. . . 
*** *** 
· . 
· . 
· . . 
0 · . 
TNFo Tiron DPI l -NAME Oxypurinol Rotenone 
treatment 
126 
Legend to Figure 4.2: 
SYEC4-10 cells at -80% confluence were stimulated with IOOU/ml TNFa for 30 minutes. 
Cells were then homogenised for lucigenin-chemiluminescence. 
A). Kinetic graph of ROS levels in TNFa treated or untreated cell homogenates. The ROS 
production was examined by using cell homogenate with lucigenin (511M) solution in the 
absence or presence ofNADPH. 
B). The average of ROS levels in TNFa treated or untreated cell homogenates in the 
presence of NADPH. Data were expressed as means ± standard deviation of three 
independent experiments. ** P<O.OI was obtained by comparing TNFa-stimulated cells to 
unstimulated cells (control) using unpaired student t-test. 
e). Effects of different enzyme inhibitors on ROS production. Homogenised cells (TN Fa-
treated) were pre incubated with or without different enzymatic inhibitors for 10 minutes at 
room temperature prior to ROS measurement by NADPH-dependent lucigenin-
chemiluminescence (lOmM Tiron: 02- scavenger; 20l1M DPI: flavoprotein inhibitor; 
1 OO~M L-NAME: NOS inhibitor; IOOI1M Oxypurinol: xanthine oxidase inhibitor; and 
50~M Rotenone: mitochondrial complex inhibitor). Data were shown as means ± standard 
deviation of three independent experiments. *** P<O.OOI was compared to homogenate 
from TNFa-stimulated cells (Dunnett's One-way ANOYA). MLU represents mean light 
unit. 
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4.2.3 Analysis of Subcellular Contribution of ROS in Endothelial Cells 
NADPH oxidase is known as a membrane-associated enzyme. To confirm this, ceIJ 
homogenates were separated into cytosol fraction and membrane fraction, and ROS 
detection of both fractions was performed by using NADPH-dependent lucigenin 
chemiluminescence. As shown in Figure 4.3, the ROS levels of cytosol fractions were 
relatively low or hardly detectable in TNFa-treated samples or control group. However, the 
ROS levels of membrane fractions in TNFa-treated samples or control group were 
detectable and the results appeared similar to the levels using whole cell homogenates. 
From the result, TNFa-induced ROS production from cell homogenate was observed in the 
membrane fraction rather than cytosol fraction. This indicates that the activation of 
NADPH oxidase is membrane-dependent. 
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Figure 4.3: Subcellular contribution of ROS production on TNFa 
stimulation. 
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SVEC4-1 ° cells were stimulated with 100V/ml TNFa. for 30 minutes. Cells were then 
homogenised in MOPS buffer and fractioned at 100,000 x g for 1 hour. The pellet 
(membrane fraction) was resuspended in MOPS buffer equal to the volume of supernatant 
(cytosol). The equal volume from each fraction was used to measure ROS production by 
NADPH-dependent lucigenin-assay. Data represented means of three independent 
experiments with standard deviation. * P<0.05 was indicated for TNFa.-treated versus their 
corresponding control (unpaired student t-test). 
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4.2.4 Examination of Transfection Efficiency 
Polyethylenimine (PEl) is a cationic polymer which has been widely used as a transfection 
reagent. To investigate the efficiency of DNA plasmid transfection into endothelial cells, 
different ratios of DNAIPEI complex were tested to determine the optimal transfection 
condition. 3 .... g p47phOX cDNA plasmid mixed with 5)11, or 10)11, or 20)11 PEl (lmg/ml) was 
used for transfection in a final 1.5ml medium in 60mm cell culture dishes. 48 hours after 
transfection, the expression levels of p47phox were detected by Western blot (Figure 4.4A). 
The p47phox expression level using 5)11 PEl for transfection did not show an increase in 
comparison to the control group (no PEl reagent). However, a two-fold increase in p47phox 
expression was observed by using 10)11 PEl for transfection, and a dramatic ten-fold 
increase in p47phOX expression was detected by using 20)11 PEl for transfection (Figure 
4.48). Cell viability was also assessed to examine the toxicity of PEl in endothelial cells by 
trypan blue exclusion assay. As shown in Figure 4.4C, there were around 2% of dead cells 
in non-transfected cells. As the increasing volume of PEl used for transfection, a steady rise 
in the percentage of dead cells was also observed. However, the cell viablity was still above 
90% when using 20)11 PEl for transfection. From these results, the plasmid DNA/PEl 
transfection ratio in following experiments in endothelial cells was 3)1g plasmid DNA 
mixed with 20111 PEl (lmglml) in 1.5ml medium in 60mm cell culture dishes. For other cell 
culture dishes or flasks, the amount of plasmid DNAIPEI used for transfection was scaled 
up and down according to culture surface area. 
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Figure 4.4: The effect of PElon transfection efficiency. 
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Legend to Figure 4.4: 
SVEC4-10 cells at 60% confluence were tranfected with p47phox cDNA plasmidlPEI mix in 
a final volume of 1.5ml serum-free medium in 60mm cell culture dishes. 4 hours later, 
equal volume of 20% FBSIDMEM medium was added and cultured for further 48 hours. 
3J!g plasmid DNA was mixed with Sill, or lOllI, or 20111 PEl (lmg/ml) to test tranfection 
efficiency by detecting p47phoX protein expression levels. Cell viability after transfection 
was also examined by trypan-blue exclusion assay. 
A). Western blotting. The optimal ratio of DNAIPEI for transfection was determined by 
detecting p47PhOX protein expression levels. U937 cells were used as positive control for 
p4 7phox -sepcific antibody. The a-tubulin was also detected as loading controls. 
B). Densitometric quantification. The expression levels ofp47phox protein in each condition 
were quantified using UVP BioSpectrum AC Imaging System sofware and normalised to a-
tubulin. Results were shown as mean values from two independent experiments. 
C). Cell viability. After 48 hours transfection, cells were trypsinised and the percentage of 
dead cells was determined by cell counting using trypan-blue exclusion assay. Results were 
expressed as mean values from two independent experiments. 
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4.2.5 The roles of p47pbOX Serine Phosphorylation on TNFa-Induced ROS Production 
in Endothelial Cells 
The p47phOX subunit is important for Nox2 activation and its phosphorylation has been 
recognised as an initial step for Nox2 complex formation. The p47phox possesses multiple 
serine phosphorylation sites at the end of its C-terminus. To investigate critical roles of 
p47phOX serine phosphorylation in TNFa-induced Nox2 activation in endothelial cells, 
p47phOX mutant plasm ids with serine to alanine mutations were introduced into endothelial 
cells, which were treated with TNFa. In TNFa-unstimulated conditions, the introduced 
p47phOX mutant plasmids did not show any significant effect on basal endothelial ROS 
production compared to pcDNA3.1 vector only (Figure 4.5A). Following 100U/ml TNFa 
challenge for 30 minutes, TNFa-induced ROS production (pcDNA3.1 vector) was 
signficantly reduced by 50% in cells transfected with several p47phox mutant plasm ids, 
including S315A, S328A, S345A, and S370A. Abolishment of phosphorylation sites at 
S303/304 and S379 showed further reduction of TNFa-induced ROS by 60% and 70% 
respectively compared to pcDNA3.1 control (Figure 4.5B). However, there were no 
significant effects on TNFa-induced ROS production when cells were transfected with 
other p47phOX mutant plasm ids, including S320A, S348A, and S359A (Figure 4.5B). To 
conclude, these results reveal the crucial roles of p47Phox serine phosphorylation on TNFa-
induced endothelial NADPH oxidase activation. 
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Figure 4.5: The Effects of p47phOX serine to alanine mutation on TNFa-
induced ROS production. 
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Legend to Figure 4.5: 
SVEC4-10 cells were tranfected with variant p47phox plasmid mutants using PEl reagent 
(lmglml). The transfection was carried out by adding premixed DNAIPEI complex (6J!g 
plasmid DNA: 40f.l1 PEl) into a final 3ml serum-free medium in lOOmm cell culture dish. 
48 hours after transfection, cells were challenged with 100U/ml TNFa for 30 minutes, and 
the ROS levels were examined by NADPH-dependent lucigenin chemiluminescence. 
A). Effects of p47PhOX mutant transfection on TNFa-unstimulated (basal) ROS production. 
The data were presented as the percentage of ROS production in the control group 
(pcDNA3.1), and the mean values were obtained from three independent experiments with 
standard deviation. 
B). Effects of p47phox mutant transfection on TNFa-stimulated ROS production. The data 
were presented as the percentage of TNFa-induced ROS production in the control group 
(pcDNA3.1), and the mean values were obtained from three independent experiments with 
standard deviation. ** P<O.Ol was compared to control group using Dunnett's One-way 
ANOVA. 
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4.2.6 The roles of p47pbos Serine Phosphorylation on TNFa-Induced on TNFa-Induced 
ERIO/2 activation 
TNFa-induced endothelial ROS are involved in many cell signalling pathways. As one of 
members of mitrogen activated protein kinases (MAPK) family, ERK is a redox-sensitive 
molecule downstream of TNFa signalling pathway, which plays an important role in cell 
survival and differentiation. To understand the role of p47phox phosphorylation in TNFa-
ERK signalling, ERK1I2 activation was examined by Western blot in p47phox mutant-
transfected cells with TNFa stimulation. Figure 4.6A shows the representative immunoblot 
of phospho-ERK1I2 and total ERK1I2 in p47phox mutant-transfected cells treated with 
TNFa. In unstimulated conditions, p47Phox mutant-transfected cells did not exhibit any 
significant differences in the basal ERK1I2 phosphorylation level compared to control 
group (pcDNA3.l vector). After 30 minutes TNFa stimulation, TNFa-induced ERKI/2 
phsophorylation levels in S328A, S345A, S370A and S379A mutant-transfected cells were 
significantly reduced by 35%, 45%, 40%, and 60% respectively in comparison with TNFa-
treated control group {pcDNA3.1 vector}. However, TNFa-stimulated cells with 
S303/304A, S310A, S315A, S320A, S348A and S359A mutant transfection did not show 
the significant change in ERK1I2 phsophorylation levels compared to the TNFa-treated 
control (pcDNA3.l vector) group (Figure 4.68). The results suggest that phosphorylation 
of S328, S345, S370 and S379 at p47Phox is invloved in TNFa-linked ERK activation. 
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Figure 4.6: The Effects of p47phox serine to alanine mutation on TNFa-
induced ERK1I2 phosphorylation. 
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Legend to Figure 4.6: 
SVEC4-10 cells were tranfected with variant p47phox plasmid mutants using PEl reagent 
(lmg/ml). The transfection was carried out by adding premixed DNA/PEl complex (61lg 
plasmid DNA: 40111 PEl) into a final 3ml serum-free medium in 100mm cell culture dish. 
Cells were chanllaged with 100U/ml TNFa for 30 minutes after 48 hours transfection, and 
the activation ofERK1I2 phosphorylation were examined by Western blotting. 
A). Representitative immunoblotting of ERK1I2 activation in p47phox mutant transfected 
cells with or without TNFa challange. 
B). Densitometric quantification. TNFa-stimulated ERK1I2 phosphorylation in different 
p47phOX mutant transfected cells was quantified from three independent experiments, using 
UVP BioSpectrum AC Imaging System sofware. The data were expressed as mean values 
with standard deviation. * P<O.05 and ** P<O.Ol were obtained by comparison with control 
group (pcDNA3.1 vector) using Dunnett's One-way ANOVA. 
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4.3 Discussion 
It has been known that TNFa-induced ROS production is involved in many cell signaling 
responses such as the activation of MAP kinases (Li et aI., 2005) and expression of 
intercellular adhesion molecules in endothelial cells (Clark et aI., 2007). It has also been 
reported that NADPH oxidase is a major endothelial ROS producer in response to TNFa 
stimulation (Li et aI., 2002b). Although two isoforms ofNADPH oxidase. Nox2 and Nox4 
. . 
are mainly expressed in endothelial cells (Li et aI., 2007). Nox2 has been revealed to playa 
major role in acute TNFa-indced ROS production via activation of p47phox by 
phosphorylation (Li et aI., 2005). However, the molecular mechanism of p47phox serine 
phosphorylation in acute TNFa-induced endothelial ROS production remains unclear. 
It has been shown that NADPH oxidase-derived ROS can be rapidly increased in human 
dermal microvascular endothelial cells (HMEC-I) in response to TNFa stimulation (Li et 
aI., 2005). This is in line with the observation that, in SVEC4-10 cells, TNFa at the 
concentration of 100U/ml induced a rapid increase of ROS production within 5 minutes, 
which peaked at 30 minutes and maintained until 60 minutes. The previous study has 
demonstrated that this acute TNFa-induced ROS production is NADPH oxidase-dependent. 
To further confirm this, enzymatic inhibitory assay was used to identify the major ROS 
producer in response to acute TNFa stimulation. In SVEC4-10 cells, pretreating cell 
homogenates with Tiron (ROS scavenger) or DPI (a flavoprotein inhibitor, NADPH 
oxidase being a flavoprotein) led to a major reduction in acute TNFa-induced ROS 
production, whereas L-NAME (nitric oxide synthase inhibitor). or oxypurinol (xanthine 
oxidase inhibitor). or rotenone (mitochondria inhibitor) did not show the effects on TNFa-
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induced ROS levels. NADPH oxidase is known as a membrane-based enzyme complex and 
its activation requires translocation of cytosolic NADPH oxidase components. In 
consistence with this, a dramatic ROS Increase induced by TNFa was observed In 
membrane fraction using SVEC4-10 cells, while levels of ROS were undetectable in 
cytosol. These results strongly suggests that acute TNFa-induced rapid ROS increase is via 
activation ofNADPH oxidase rather than other enzymatic ROS sources in endothelial cells. 
Activation of endothelial NADPH oxidase by acute TNFa stimulation requires p47pho)( 
serine phosphorylation. At the C-terminus of p47phO", there are at least ten serines that may 
be involved in phosphorylation. In SVEC4-10 cells transfected with different p47phox serine 
to alanine mutant plasm ids, overexpressed p47Pho)( or mutated had no effect on the basal 
levels of ROS production, indicating that the activation of Nox2 is more likely to depend 
on the serine phosphorylated p47PhO)(, rather than expression level of p47pho)(. In stimulated 
conditions, phosphorylation at sites ofp47phO)( S303/304, S315, S328, S345, S370 and S379 
were involved in TNFa-induced p47phox activation, and elimination of these 
phosphorylation sites led to a reduction ofNADPH oxidase activity. However, the mutation 
at sites of p47phox S320, S348 and S359 had little effect on NADPH oxidase activity. 
Among these phosphorylated serines, phosphorylation at sites of p47phox S303/304 and 
5379 is more critial, as the abolishment of these phosphorylation sites showed a major 
defect in TNFa-induced NADPH oxidase activity. In support with this, the important roles 
of p47phOX 8303/304 and S379 phosphorylation in the regulation of NADPH oxidase 
activation are also revealed in other studies using phagocytes (Faust et aI., 1995; Inanami et 
aI., 1998). 
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The NADPH oxidase activation via p47phox phosphorylation is involved in acute TNFa-
induced ERK1I2 signalling pathway in endothelial cells (Li et aI., 2005). In unstimulated 
conditions, SVEC4-10 cells with overexpression of p47phox or mutated variants did not 
show the significant effects on the basal levels of phosphorylated ERKl/2. On TNFa 
stimulation, mutation at sites of p47phox S320, S348 and S359, as expected, had no effects 
on TNFa-induced ERK1I2 phosphorylation, while TNFa-induced ERKl/2 phosphorylation 
was signficantIy reduced when SVEC4-10 cells were transfected with p47phox S328A, 
S345A, S370A and S379A mutant plasmids. Unexpectedly, mutation at sites of p47phox 
S303/304 and S315 had no effect on TNFa-induced ERK 1 12 phosphorylation, but 
significantly reduced TNFa-induced ROS production. This phenomenon is currently 
difficult to be explained. According to literatures, we speculate that phosphorylation at 
S303/304 and S315 sites is important for p47phox to form a fully activated shape, but has no 
effect on p47phOX_TNF receptor associated factor 4 (TRAF4) binding, which upregulates 
ERK1I2 activation. 
To sum up, in endothelial cells, acute TNFa-induced p47phox phosphorylation occurs at 
several serine residues, including S303/304, S3l5, S328, S345, S370 and S379. Among 
these serine residues, phosphorylation at p47phox S303/304 and S379 plays a more 
imorportant role in the regulation ofNADPH oxidase activation. However, the discrepancy 
of their roles in TNFu-ERKI/2 signalling strongly indicates a different molecular 
mechanism ofp47phox serine phosphorylation during NADPH oxidase activation. 
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Chapter 5: Investigation of p47phox Serine303/304 
Phosphorylation in TNFa-Induced NADPH oxidase Activation 
and MAPK Phosphorylation in Endothelial Cells of Different 
Species and in COS7phox Cells 
5.1 Introduction 
As one of the major regulatory subunits ofNADPH oxidase, the p47phox plays an important 
role in translocating and targeting other subunits to Nox2 (DeLeo and Quinn, 1996). From 
N-terminal amino acid sequence, p47phox sequentially contains one phox homology (PX) 
domain, two SH3 domains, one auto-inhibitory region (AIR), and one proline-rich region 
(PRR). In resting state, p47phOX SH3 domains interact intramolecularIy with non-
phosphorylated polybasic AIR. However, in the activated form, the p47phox SIB domains 
released by phosphorylated AIR are occupied by the PPR of the cytoplasmic domain of 
p22phOX (EI-Benna et aI., 2009; Huang and Kleinberg, 1999; Lee et aI., 2000). 
The analysis of p47phOX phosphorylation sites has revealed that ten serines between S303 
and S379 are phosphorylated when human neutrophils are stimulated with phorbol 12-
myristate I3-acetate (PMA), the PKC activator (El Benna et aI., 1994). Two serines S303 
and S304, located in p47PhOX auto-inhibitory region, are two major phosphorylated sites in 
pMA-induced NADPH oxidase activation. In EBV-transformed p47Phox-deficient 
lymphocytes B cells, single serine to alanine mutation on p47phox S303 or S304 site showed 
a 50% decrease of PMA-induced ROS production (Faust et aI., 1995). Further studies by 
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the introduction of dual serine to alanine mutation on S303/304 exhibited an almost 
defective production of superoxide (Ago et aI., 1999; Inanami et aI., 1998). 
COS7 cells are a monkey kidney cell line, which does not express phagocyte-type NADPH 
oxidase subunits, including Nox2, p22PhOX, p40PhoX, p67phox and p47phox (Price et aI., 2002; 
Yu et aI., 1997). COS7 cells with transgenic expression of Nox2 and p22phox were firstly 
reconstituted by Dinauer et al group (Yu et aI., 1997). In response to PMA stimulation, the 
Nox2/p22phox-reconstituted COS7phox cells transiently co-transfected with p67phox cDNA 
plasmid and p47phOX S303/304A plasmid showed a major defect in NADPH oxidase-derived 
ROS production when compared to these cells transiently transfected with p67phox cDNA 
plamsid and p47phOX cDNA plasmid (Price et aI., 2002). However, this reduced ROS 
production was restored when Nox2/p22phox-reconstituted COS7phox cells were transiently 
transfected with p67phOX and p47phox S303/304E (The serine to glutamate mutation is 
capable of mimicking phosphorylation) (Price et aI., 2002). 
The important role of p47PhOX S303/304 phosphorylation for Nox2 activation has been well 
studied in the past. However, these studies based on PMA-induced activation can not 
exclude the possibility that the role of p47phox S303/304 phosphorylation may be different 
in response to physiological stimuli. In addition, though phagocyte-type NADPH oxidase is 
expressed in vasculature, the divergent functions ofNADPH oxidase-derived ROS between 
immune system and cardiovascular system also indicate the role of p47phox S303/304 
phosphorylation may differ in different cell types. Therefore, it is well worthy investigating 
the regulatoy mechanism of p47phox S303/304 phosphorylation for Nox2 activation in 
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cardiovasuclar system. So far, there is only one report showing that expression of p47phox 
S303/304A suppresss the redox-sensitive signal by reducing ROS production in vascular 
smooth muscle cells (VSMC) in response to acute angiotensin II (Ang II) stimulation 
(Adachi et aI., 2004). It is still unclear whether p47phox S303/304 phosphorylation is 
essencital for Nox2 activtion in endothelial cells in response to TNFastimulation. In my 
previous study (Chapter 4), abolishment of phosphorylation sites at p47phox S303/304 
showed a major decrease in acute TNFa-induced ROS production. Here, the role ofp47phox 
S303/304 phosphorylation in acute TNFa-induced NADPH oxidase activation was further 
investigated using mouse endothelial cell line (SVEC4-1 0 cells), primary endothelial cells 
of different species (mouse coronary microvascular endothelial cells and human lung 
endothelial cells), reconstituted COS7phox cell model, and p47PhOX knockout mouse coronary 
microvascular endothelial cells. 
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5.2 Results 
5.2.1 NADPH Oxidase Activity in Membrane Fractions in SVEC4-10 cells 
NADPH oxidase is a membrane-dependent enzyme. Therefore, cellular membrane fractions 
were used to investigate the important role ofp47phox S303/304 phosphorylation on TNFa-
induced ROS production by NADPH-dependent lucigenin chemiluminescence. As shown 
in Figure 5.1, pcDNA3.1 vector-transfected SVEC4-10 cells maintained a basal level of 
ROS production in the absence of TNFa stimulation. This low level of ROS production 
was not significantly changed by overexpressing p47phox or p47phox S303/304A in SVEC4-
10 cells. After 30 minutes ofTNFa treatment, an approximately two-fold increase in ROS 
production was detected in the pcDNA3.1 vector-transfected cells. This significant increase 
in ROS level was also observed in p47phOX cDNA-transfected cells; however overexpression 
of p47phOX did not give rise to higher ROS production when compared with TNFa-
stimulated ROS production in pcDNA3.1 vector group. In p47phox S303/304A-transfected 
cells, TNFa-induced ROS production was significantly reduced by 50% when compared to 
the increase of ROS production in TNFa-stimulated cells transfected with pcDNA3.1 
vector. This result strongly suggests that the serine to alanine mutation on p47phox S303/304 
inhibits TNFa-induced NADPH oxidase activation in cellular membrane fractions in 
SVEC4-10 cells. 
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Figure 5.1: The effect of p47phox S303/304A on TNFa-induced NADPH 
oxidase activation in membrane fractions in SVEC4-10 cells. 
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SVEC4-10 cells transfected with pcDNA3.l vector, p47phox eDNA, or p47phox S303/304A 
plasmids were treated with lOOU/ml TNFa for 30 minutes. Cellular ,membrane fractions 
were isolated from cell homogenates using gradient ultracentrifugation (Chapter 2. I 2), and 
an equal amount of membrane protein from each sample was used for NADPH-dependent 
lucigenin chemiluminescence. The Data were shown as mean values of three independent 
experiments with standard deviation. ** P<O.OI was obtained by comparing TNFa-treated 
cells transfected with pcDNA3.l vector, or p47phox cDNA to their corresponding control, 
and # p<0.05 was obtained by comparing TNFa-treated cells transfected with p47phox 
S303/304A to TNFa-treated cells transfected with pcDNA3. I vector (Paired student T-test). 
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5.2.2 Intracellular ROS Detection in SVEC4-10 cells 
NADPH oxidase has been implicated in TNFa-induced intracellular ROS production in 
endothelial cells. To understand whether the p47phox S303/304 phosphorylation is involved 
in the procedure, the effect of S303/304 mutation on TNFa-induced intracellular ROS 
production was detected by the 2, 7-dichlorofluoroscein (DCF) assay. As shown in Figure 
5.2A, endothelial cells generate intracellular ROS under normal culture conditions, and this 
low level of ROS can be elevated by TNFa stimulation within 30 minutes. The levels of 
intracellular ROS under different conditions were quantified by fluorescent density (Figure 
5.2B). In the absence ofTNFa stimulation, a low level of intracellular ROS production was 
detected in SVEC4-10 cells transfected with pcDNA3.1 vector plasmid. In cells with 
overexpression of p47phOX, this basal ROS level was also observed without significant 
change compared to cells transfected with pcDNA3.1 vector only. Similarly, the 
overexpression of p47PhOX S303/304A in SVEC4-1 0 cells did not reveal a significant change 
in basal intracellular ROS production compared to cells trasnfected with pcDNA3.1 vector. 
With TNFa treatment for 30 minutes, a two-fold intracellular ROS increase was observed 
in pcDNA3.l vector transfected cells compared to untreated control group (pcDNA3.1 
vector). By overexpression of p47phOX, TNFa-induced intracellular ROS level was 
significantly increased as well, but maintained the similar level to TNFa-induced cells 
transfected with pcDNA3.1 vector. However, this TNFa-induced ROS production was 
significantly reduced in cells with overexpression of p47phox S303/304A, indicating that 
p47phOX S303/304A mutation has the adverse effect on TNFa-induced intracellular ROS 
production in SVEC4-10 cells. 
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Figure 5.2: The effect of p47phox S303/304A on TNFa-induced 
intracellular ROS production in SVEC4-10 cells. 
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Legend to Figure 5.2: 
Cells transfected with pcDNA3.1vector, p47phox cDNA, or S303/304A plasmids were 
incubated with 5JlM CM-H2DCFDA for 10 minutes and then treated with 100U/ml TNFa 
for 30 minutes. Intracellular ROS was immediately detected under a fluorescent 
microscope with an excitation of 488nm and a 515/30 bandpass emission filter. 
A). Representitative images (200x magnification) of intracellular ROS dectection in 
transfected SVEC4-1O cells. 
B). Quantification. The fluorescent densities of five images for each condition were 
quantified using Digital Pixel Simple PCI sofeware. Data were expressed as mean values of 
representitative three independent experiments with standard deviation. The paired student 
T -test was used for statistical analysis. ** P<O.O 1 was obtained by TNFa-treated cells 
transfected with pcDNA3.1 vector, or p47phox cDNA to their corresponding control. ## 
p<O.Ol was obtained by comparing TNFa-treated cells transfected with p47phox S303/304A 
to TNFa-treated cells transfected with pcDNA3.1 vector. 
149 
5.2.3 Activation of ERI(1 12 , p38 MAPK and JNK in SVEC4-10 cells 
Mitogen activated protein kinases (MAPK), including ERKII2, p38 MAPK and JNK, are 
redox-sensitive signalling molecules which can respond rapidly to TNFa stimulation via 
NADPH oxidase. To investigate the role of p47phox S303/304 phosphorylation during 
MAPK activation, the effects of p47phox S303/304A mutation on TNFa-induced 
phosphorylation of ERKII2, p38 MAPK and JNK were examined by Western blotting. In 
TNFa-unstimulated SVEC4-10 cells, there were relatively low levels of ERK 112 activity in 
SVEC4-10 cells transfected with pcDNA3.1 vector, p47phox cDNA or p47phox S303/304A 
plasmids, as well as undetectable levels of p38 MAPK and JNK activity. However, TNFa 
can induce a rapid increase in ERK1I2 phosphorylation within 30 minutes, which was 
simultaneously accompanied by the significant increase in p38 MAPK and JNK 
phosphorylation in cells transfected with pcDNA3.1 vector. Cells with an overexpression of 
p47phOX also showed the significant increase in TNFa-induced ERKII2, p38 MAPK and 
JNK phosphorylation levels, nevertheless these were comparable to those in TNFa-
stimulated cells transfected with pcDNA3.1 vector. Interestingly, the introduction of 
p47phOX S303/304A into the SVEC4-10 cells did not exhibit the significant effect on TNFa-
induced ERK1I2, p38 MAPK and JNK phosphorylation levels when compared to the levels 
obtained in cells trasnfected with pcDNA3.1 vector (Figure 5.3A and 5.3B). The 
overepxression of p47phox levesl were also examined to exclude the possibility that the 
unchanged ERK1I2, p38 MAPK and JNK phosphorlyation levels in cells transfected with 
p47PhOX S303/304A are due to failure oftransfection (Figure 5.3A). Therefore, these results 
indicate that p47phox S303/304A mutation is not involved in TNFa-induced ERK 112, p38 
MAPK and JNK activation. 
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Figure 5.3: The effects of p47Phox S303/304A on TNFa-induced ERK1I2 , 
p38 MAPK and JNK activation in SVEC4-10 cells 
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Legend to Figure 5.3: 
Cells transfected with pcDNA3.l vector, p47phox eDNA, or p47phox S303/304A plasm ids 
were treated with IOOU/ml TNFa for 30 minutes. Cells were homogenised and prepared for 
Western blotting to examine the phosphorylation ofERK1I2, p38 MAPK and JNK. 
A). Representitative images of immunoblotting to show TNFa-induced phosphorylation 
levels of ERK1I2, p38 MAPK and JNK in transfected cells. Total levels of ERKI/2, p38 
MAPK and JNK were used as loading controls. The detection of p47phox expression was 
used to confirm the transfection efficiency, and a-tubulin was used as a loading control for 
p4 7phox detection. 
B). Quantification. The density of phosphorylation and total protein expression of ERK 112, 
p38 MAPK and JNK were quantified using UVP AC imaging system software. The 
phosphorylation levels were finally normalised according to the corresponding total protein 
expression. The data were expressed as mean values of three independent experiments with 
standard deviation. The paired student T-test was used for statistical analysis. ** p<O.Ol 
and *** p<O.OOI were obtained for TNFa-induced phosphorylation levels compared to 
TNFa-untreated phosphorylation levels in cells transfected with pcDNA3.1 vector. 
152 
5.2.4 NADPH oxidase activity in primay endothelial cells 
In addition to cell lines, primary endothelial cells were used to verify the role of p47phox 
S303/304 phosphorylation in NADPH oxidase activation. As shown in Figure 5.4A, in the 
absence of TNFa, there were low levels of ROS production in wild-type mouse coronary 
microvascular endothelial cells transfected with pcDNA3.1 vector plamids. This basal level 
of ROS was not significantly changed transfecting cells with p47phox S303/304A plasimd. 
Following TNFa treatment, a two-fold ROS increase was observed in cells transfected with 
pcDNA3.1 vector. The TNFa-induced ROS production was significantly reduced in cells 
transfected with p47PhOX S303/304A when compared to the TNFa-stimulated vector group 
(Figure 5.4A). In primary human lung endothelial cells, cells transfected with pcDNA3.1 
vector or p47phox S303/304A showed a similar low level of ROS production without TNFa 
treatment. After TNFa stimulation for 30 minutes, TNFa induced a two-fold increase of 
ROS production in cells transfected with pcDNA3.1 vector. By transfecting cells with 
p47phOX S303/304A plasmid, TNFa-induced ROS production was significantly reduced 
compared to that in cells transfected with pcDNA3.1 vector (Figure 5.4B). These results 
suggest that p47phOX S303/304A mutation exhibits the inhibitory role for NADPH oxidase 
activation in both mouse and human primary endothelial cells. 
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Figure 5.4: The effect of p47phOX S303/304A on TNFa-induced NADPH 
oxidase activity in primary endothelial cells. 
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Legend to Figure 5.4: 
Primary mouse and human endothelial cells were transfected with pcDNA3.1 vector or 
p47phox S303/304A plamsid and stimulated with 100 Vlml mouse TNFa or human TNFa 
for 30 minutes. Cells were homogenised and equal amount of cell homogenate in each 
sample was used to measure ROS proudction by NADPH-dependent lucigenin 
chemiluminescence. 
A). Mouse coronary microvascular endothelial cells. Coronary microvascular endothelial 
cells were isolated from wild-type C571B16 background male mice. Cells cultured at 
passage 2 were used for tranfection. Data were expressed as mean values of two 
independent experiments (n=3 in each experiment) with standard deviation. 
B). Human primary lung endothelial cells. Human primary lung endothelial cells at pas age 
7-9 were used for transfection. Data were expressed as mean values of three samples in 
each condition (n=3 in single experiment). 
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5.2.5 NADPH oxidase activity in COS7 (Noxl/p22phOX) and p47ph01 knocknout 
coronary microvascular endothelial cells 
To confirm the imporant role of p47Phox S303/304 phosphorylation on TNFa-induced 
NADPH oxidase activation, the p47phox-deficient cell model and p47phox knockout coronary 
microvascular endothelial cells were transfected with p47phox cDNA and p47phox S303/304A 
plasmids. As the COS7 cell line does not express NADPH oxidase subunits, COS7 cells 
previously stably transfected with Nox2 and p22phox were further double transiently 
transfected with p67phox cDNA and p47phox eDNA, or p67phox cDNA and p47phox S303/304A. 
COS7 (Nox2/p22PhOX) cells expressing p67phox and p47phox showed a significant increase of 
ROS production with TNFa stimulation when compared to cells without TNFa stimulation. 
When COS7 (Nox2/p22PhOX) cells expressed p67phOX and p47phox S303/304A, the basal ROS 
level (TN Fa-untreated) was not changed, but TNFa-induced ROS production was inhibited 
when compared to that in COS7 (Nox2/p22phox) cells expressing p67phox and p47phox. In 
p47phOX knockout coronary microvascular endothelial cells tranfected with p47phox cDNA 
plasmid, TNFa-induced ROS production exhibited a two-fold increase when compared to 
basal ROS (TNFa-untreated). Although p47PhOX knockout cells transfected with p47phox 
S303/304A plasmid did not show the significant change on the basal ROS production, 
TNFa-induced ROS production was inhibited when compared to that in p47phox knockout 
cells transfected with p47phox cDNA plasmid. Therefore, these data further confirm that the 
p4 7phox S303/304A mutation inhibits NADPH oxidase activation. 
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Figure 5.5: The effect of p47phox S303/304A on TNFa-induced NADPH 
oxidase activity in Nox2/p22 phox-reconstituted COS7 cells and p47Phox 
knockout mouse coronary microvascular endothelial cells. 
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Legend to Figure 5.5: 
A). Nox2/p22phox COS7 cell line. COS7 cells stably expressing Nox2 and p22phox were 
tansiently transfected with the mix of p67phox cDNA and p47phox cDNA, or the mix of 
p67phox cDNA and p47phox S303/304A at the ratio of 1:1. Cells were treated with 100 Vlml 
human TNFa for 30 mintues or left untreated as a negative control. The equal amount of 
cell homogenate from each sample was used to measure ROS production by NADPH-
dependent lucigenin chemiluminescence. Data were presented as the mean values of three 
independent experiments with standard deviation. The unpaired studuent T -test was used to 
analyse the statistical significance. ** P<O.OI was obtained for the TNFa-stimulated 
p47PhOX cDNA sample compared to the p47phox cDNA control sample. ## P<O.OI was 
obtained for TNFa-stimulated p47phox S303/304A sample compared to TNFa-stimulated 
p47phOX cDNA sample. 
B). p47phOX knockout mouse coronary microvascular endothelial cells. Coronary 
microvascular endothelial cells isolated from p47phox knockout male mice (backcrossed 
from svl29 to C571B16 background) were cultured until passage 2. Cells were transiently 
transfeced with p47phOX cDNA or p47Phox S303/304A plasmid, and then treated with 
100U/ml mouse TNFc for 30 miuntes or left untreated as negative controls. The equal 
amount of homogenised protein sample was used to detect ROS production by NADPH-
dependent lucigenin assay. Data were shown as the mean values of three independent 
experiments with standard deviation. The paired student T -test was used for statistical 
analysis. ** P<O.OI was obtained for the TNFa-stimulated p47phox cDNA sample compared 
to p47phOX cDNA control sample. ## P<O.OI was obtained for the TNFa-stimulated p47phox 
S303/304A sample compared to TNFa-stimulated p47phox cDNA sample. 
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5.2.6 ERK1I2 activation in p47phOX knockout mouse coronary microvascular 
endothelial cells 
To further investigate the role of p47phox S303/304 phosphorylation on TNFa-induced 
ERK1I2 activation, the p47phox knockout mouse coronary microvascular endothelial cells 
transfected with p47phox cDNA or p47Phox S303/304A plasm ids were challenged with 0 
TNFa for 30 minutes. The changes of ERKl/2 phosphorylation were examined by 
immunoblotting. In the unstimulated conditions, the p47phox knockout endothelial cells 
transfected with p47phox cDNA showed a low level of phosphorylated ERK 112. This basal 
level of phosphorylated ERK1I2 was not significantly changed in p47phox knockout 
endothelial cells transfected with p47phox S303/304A. In the presence of TN Fa, a two-fold 
increase of ERK 112 phosphorylation was observed in the p47phox knockout endothelial cells 
transfected with p47phOX eDNA. However, the p47phox S303/304A mutation did not show a 
significant change in TNFa-induced phosphorylated ERK1I2 level (Figure 5.6A and 5.68). 
The p47phox protein expression was also detected to examine the transfection efficiency 
(Figure 5.6A). By using this p47phox knockout endothelial cells, these results strongly 
suggest that the p47PhOX S303/304A mutation has no effect on TNFa-induced ERK1I2 
activation. 
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Figure 5.6: The effect of p47PhOX S303/304A on TNFa-induced ERK1I2 in 
p47phOX knockout primary mouse coronary microvascular endothelial cells. 
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Legend to Figure 5.6: 
Coronary microvascular endothelial cells isolated from p47phox knockout mice were 
cultured until passage 2. Cells were then transiently transfected with p47phox cDNA or 
p47phOX S303/304A plasmid. 48 hours after tranfection, cells were treated with 100 U/ml 
TNFa for 30 minutes or left untreated as negative controls. The level of ERK 112 
phosphorylation was examined by Western blotting. 
A). Representatitive images of immunoblotting to show the phosphorylation level of 
ERK1I2 as well as the expression levels of total ERK, p47phox and a-tubulin. Total ERK1I2 
was used as a loading control for Phosphoylated ERK1I2. The detection of p47phox was 
used to confirm the transfection efficiency into cells and check the protein expression levels. 
The a-tubulin was used as loading control for p47PhOX protein expression. 
B). Quantification. The density of phosphorylated ERK1I2 and total ERK1I2 bands was 
quantified using UVP imaging system software. The levels ofERK1I2 phosphorylation was 
normalised according to total ERK1I2 protein expression. Data were expressed as the mean 
values of three independent experiments with standard deviation. Paired student T-test was 
used for statistical analysis. ** P<O.Ol was indicated for TNFa.-stiumlated sample 
compared to control sample in p47phox cDNA or p47phox S303/304A-transfected cells. 
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5.3 Discussion 
In the activation of NADPH oxidase, phosphorylation of p47pho)( is an important initiating 
event. At the C-terminus of p47pho", serine 303 and serine 304 are two critical 
phosphorylation sites for NADPH oxidase activity, which is supported by the report that 
p47phO)( S303/304A double mutation led to a major defect in PMA-induced NADPH 
oxidase activity in phagocytic cells (Inanami et aI., 1998). However, it remains unclear the 
role ofp47PhO)( S303/304 phosphorylation in TNFa-induced NADPH oxidase activation and 
MAPK signalling in endothelial cells. 
SVEC4-10 cells transfected with p47Pho)( S303/304A plasmid showed a significant 
reduction in TNFa-induced ROS production using whole cell homogenates. This is 
consistent with the results when membrane fractions from cells transfected with p47PhO)( 
S303/304A plasmid were used for ROS measurement. Previous finding that NADPH 
oxidase components (Nox2 and p22pho)() in endothelial cells are localised in the 
endoplasmic endothelium suggests that endothelial NADPH oxidase produces intracellular 
ROS. This is supported by the images showing a detectable intracellular fluoresence in 
endothelial cells in the CM-DCFDA experiment (Li and Shah, 2002). In SVEC4-10 cells, 
increased intracellular ROS production by TNFa stimulation was significantly reduced in 
cells transfected with p47pho)( S303/304A plasmid. Using different experimental methods, it 
can be concluded from these results that phosphorylation of p47pho)( S303/304 plays a vital 
role in TNFa-induced NADPH oxidase activation in SVEC4-10 cells. 
NADPH oxidase is involved in TNFa-induced MAPK activation in endothelial cells (Li et 
aI., 2005). In support with this, my results also showed that phosphorylation levels of 
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ERK1I2, p38 MAPK and JNK were increased in response to acute TNFa stimulation (30 
minutes) in SVEC4-10 cells transfected with pcDNA3.1 vector or p47phox cDNA plasm ids. 
Interestingly, p47Phox S303/304A mutation had little effect on TNFa-induced ERK1I2, p38 
MAPK and JNK activation. This finding indicates that phosphorylation of p47phox 
S303/304 may not be directly involved in acute TNFa-induced MAPK activation. 
In addition to cell line, mouse coronary microvascular endothelial cells and human lung 
endothelial cells were also used to investigate the role ofp47phox S303/304 phosphorylation 
in TNFa-induced NADPH oxidase activation. As expected, both mouse and human primary 
endothelial cells transfected with p4 7phox S303/304A plasmid exhibited a reduced TNFa-
induced ROS production. Although three different cell types in two species showed similar 
results, the methodology used by overexpression of mutated p47phox can not exclude the 
effect of endogenous p47phox in the experiments. To rule out this possibility, Nox2/p22phox_ 
reconstituted COS7phox cells co-transfected with p67phox eDNA plasmid and p47phox 
S303/304A plasmid showed no increase in TNFa-induced ROS production. The faiure of 
TNFa-induced ROS production was futher confirmed by transfecting p47Phox knockout 
mouse coronary microvasuclar endothelial cells with p47phox S303/304A plasmid. However, 
the p47phOX S303/304A mutation also had no effect on TNFa-induced ERK1I2 activation in 
p4 7phox knockout mouse endothelial cells. 
To conclude, p47phOX S303/304 phosphorylation plays an important role in regulation of 
TNFa-inducedNADPH oxidase activation, but is not involved in TNFa-induced MAPK 
activation in endothelial cells. 
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Chapter 6: General Discussion and Future Work 
6.1 General Discussion 
Endothelial generation of ROS is necessary in maintaining cardiovascular homeostasis. 
Excessive ROS generation (oxidative stress) results in endothelial dysfunction, which is 
closely linked to various cardiovascular diseases such as heart failure, cardiac hypertrophy, 
atherosclerosis and diabetes (Bauersachs and Schafer, 2004; Cai and Harrison, 2000; 
MacCarthy et aI., 2001; Potenza et aI., 2009; Victor et aI., 2009). Several sources of ROS 
generation in endothelial cells have been discovered, including mitochondria (Therade-
Matharan et aI., 2005), xanthine oxidase (Meneshian and Bulkley, 2002), uncoupled NO 
synthases (Vasquez-Vivar et aI., 1998), NADPH oxidase and cytochrome p450 (Fleming, 
2001), among which accumulating evidences have shown that NADPH oxidase is a major 
source of ROS generation in endothelial cells (Babior, 2000; Griendling et aI., 2000; Ray 
and Shah, 2005; Rueckschloss et aI., 2003). At least seven different isoforms of NADPH 
oxidase (Noxl-Nox5, Duoxl and Duox2) are widely expressed in different tissues (Bedard 
and Krause, 2007; Kawahara et aI., 2007; Nauseef, 2008). In endothelial cells, Nox2 and 
Nox4 are mainly expressed (Li et aI., 2007). Nox2 is originally discovered as phagocyte-
type NADPH oxidase, and it is an enzyme complex, comprsing of membrane-associated 
Nox2/p22phOX heterodimer, and other cytosolic regulatory subunits. 
At least four cytosolic subunits ofNADPH oxidase (Rae, p40PhOX, p47phox and p67PhOx) have 
been found so far, and the p47phOX has been demonstrated to be capable of undergoing 
phosphorylation during NADPH oxidase activation (El Benna et aI., 1994). Although the 
studies in leukocytes have shown multiple serine phosphorylation sites at C-terminal end of 
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p47phOX in response to various stimuli (El Benna et aI., 1996a), it still remains unknown 
whether or not and how p47PhOX phosphorylation is involved in the regulation of endothelial 
ROS production. Thus, in this Ph.D project, I used in vitro site-directed mutagenesis to 
change the code often serines (S303/304, S315, S320, S328, S345, S348, S359, S370 and 
5379) for that of alanines (a nonpolar and unphosphorylated amino acid) in p47phox eDNA 
plasmid. To facilitate screening in the mutagenesis, a silent mutation was also introduced to 
create or abolish a restriction digest site in the proximity of serine to alanine code change 
during primer design. My results show that the site-directed mutagenesis is a powerful and 
efficient technique for generating point mutation as required. 
TNFa is an inflammatory cytokine, which exhibits divergent biological functions in 
different cell types (Wajant et aI., 2003). In endothelial cells, TNFa-induced ROS 
generation is involved in meidating mUltiple signal transduction pathways, including 
activation of several members of mitogen-activated protein kinase (MAPK) family (Li et aI., 
2005; Mong et aI., 2008; Sakon et aI., 2003), as well as increased expression levels of 
cellular adhesion molecules such as intercellular adhesion molecule 1 (ICAM-I), which is 
required for the adhesion of polymorphonuclear neutrophils to endothelial cells during 
vascular inflammation (Rahman et aI., 2000; Soccio et aI., 2005; True et aI., 2000). Prvious 
study has demonstated that TNFa is a strong activator of endothelial NADPH oxidase by 
inducing p47phOX serine phosphorylation (Li et aI., 2005). However, it remains unknown 
which serine residues are involved in TNFa-induced endothelial NADPH oxidase 
activation. In this study, my results clearly showed that multiple serines, including p47phox 
5303/304, S315, S328, S345, S370 and S379, underwent rapid phosphorylation in response 
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to acute TNFa stimulation. Abolishment of these phosphorylation sites induced an effective 
reduction of TNFa-induced ROS production. Among these serines, phosphorylation of 
S303/304 and S379 has shown to be more important for p47phox to form an activated shape. 
In support with this, the important roles of these serines are also observed in PMA-induced 
p47phOX phosphorylation in lymphocytes (Faust et aI., 1995; Inanami et aI., 1998). In 
contrast, p47phox phosphorylation induced by TNFa only occurs at p47Phox S345 In 
neutrophils (Dang et at., 2006). This partial p47phox phosphorylation is a common event of 
priming of neutrophils, which subsequently faciliates fMLP-induced further p47phox 
phosphorylation and respiratory burst of superoxide (EI-Benna et aI., 2008). This 
discrepancy in TNFa-induced p47phox phosphorylation between neutrophils and endothelial 
cells suggests a different molecular signalling pathway in the process. In response to 
different stimuli, p47PhOX is phosphorylated on selective sites by different type of protein 
kinases such as protein kinase C isoforms (Fontayne et aI., 2002), protein kinase A (El 
Benna et aI., 1996a), MAPkinases ERK 112 and p38 (El Benna et aI., 1996b), Akt (Chen et 
aI., 2003a), p21-activated kinase (PAK) (Martyn et aI., 2005) and Src kinase (Touyz et aI., 
2003). In neutrophils, phosphorylation at p47phOX S345 is directly induced by ERK1I2 or 
p38 MAPK in TNFa stimulation, whereas TNFa-induced p47phox phosphorylation in 
endothelial cells is via activation of PKC~, an aypical PKC isoform (Frey et aI., 2002). 
Although the whole moleuclar mechanism is not fully understood yet, these findings may at 
least demonstrate that the molecular mechanism of NADPH oxidase activation by TNFa 
may vary in different cell types. 
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NADPH oxidase has been reported to be involved in TNFa-induced MAPK activation in 
endothelial cells, and p47phOX plays a key role in the process, which is supported by the 
report that TNFa fails to activate ERK1I2 phosphorylation in p47Phox knockout coronary 
microvascular endothelial cells (Li et aI., 2005). However, it not clear which serines are 
invovled in p47phOX mediated NADPH oxidase activation and TNFa-induced ERK1I2 
signalling. My data showed that the reduction of acute TNFa-induced ROS production in 
SVEC4-10 cells transfected with p47phox S328A, S345A, S370A or S379A was 
accompanied by an effective decrease in TNFa-induced ERK1I2 activation. Interesting, 
p47PhOX S303/304A mutation did not have the effect on TNFa-induced ERKI/2 
phosphorylation, but significantly reduced TNFa-induced ROS production. This 
phenomenon is currently unexplainable. Several papers have mentioned that p47phox does 
not only associate with two other cytosolic NADPH oxidase subunits p40Phox and p67phoX, 
but also have a close interaction with TNF receptor-associated factor 4 (TRAF4) when 
endothelial cells are stimulated with TNFa (Li et aI., 2005; Xu et aI., 2002). The binding of 
TRAF4 to p47phOX has been reported to locate between residues 299 to 390 at the C-
terminus of p47PhOX, which contains a cluster of serine residues that can be phosphorylated 
during activation (Xu et aI., 2002). It is possible that p47Phox phosphorylation faciliates its 
interaction with TRAF4 and subequenly tranlocate it to membrane. This speculation is 
supported by the immunoprecipitation experiment showing that TNFa-induced interaction 
between p22phOX and p47phox is also accompanied by an inreased interaction between p47phox 
and TRAF4 (Li et aI., 2005). In this report, they also show that TNFa fails to induce 
ERIO/2 activation, but has no effect on TNFa-induced p47phox phosphorylation in HMEC-
1 cells with knockdown ofTRAF4 (Li et aI., 2005). Similarly, another report discovers that 
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overexprerssion of TRAF4 is capable of increasing ERK1I2 phosphorylation (Kedinger et 
aI., 2008). Nevertheless, TRAF4 is found to directly associate with MEKK4 and positively 
regulate MAPK kinase kinase 4 (MEKK4) activtion, which is the upstream sigalling 
molecule in p38 MAPK and JNK pathways (Abell et aI., 2007; Abell and Johnson, 2005). 
On the other hand, multiple p47phox serines undergo sequential phosphorylation during 
NADPH oxidase activation, and p47phox S303/304 phosphorylation is though to be post-
phosphorylational event which occurs after p47phox translocation (Johnson et aI., 1998). 
This is supported by the finding that, in lymphocytes, p47phox S303/304A mutation inhibits 
PMA-induced ROS production, but has no effect on p47phox translocation to membrane 
(lnanami et aI., 1998), while p47phox S379A mutation inhibits both (Faust et aI., 1995). 
Based on literature search, it is speculated that TRAF4 is an intermediate molecule in acute 
TNFa-MAPK signalling pathways and the role of p47phox phosphorylation in the process is 
to faciliate TRAF4 to membrane targeting. 
The specific role of p47PhOX S303/304 phosphorylation on acute TNFa-induced ROS 
production by SVEC4-10 cells had been examined using different methods, including 
lucigenin-chemiluminescence and DCF assay. The effect of p47phOX S303/304 
phosphorylation on promoting TNFa-induced endothelial ROS production was also verified 
using primary endothelial cells from different species (mouse coronary microvascular 
endothelial cells and human lung endothelial cells, in Figure 5.4). These data showed a 
consistent reduction of acute TNFa-induced ROS production in cells transfected with 
p47phOX S303/304A mutated plasmid. This was further confirmed using Nox2/p22phox_ 
reconstituted COS7phox cells which do not express p47phox (Price et aI., 2002; Yu et aI., 
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1997). Reconstituted COS7phox cells co-transfected with p67phox cDNA plasmid and p47phox 
S303/304A mutated plasmid exhibited a defective NADPH oxidase activity in response to 
acute TNFa stimulation. The similar result was also observed in p47phox knockout coronary 
microvascular endothelial cells transfected with p47phox cDNA plasmid and p47phox 
S303/304A mutated plasmid. Consistent with the results obtained in SVEC4-10 cells, 
TNFa had little effect on acute TNFa-inducd ERK1I2 activation in p47phox knockout 
coronary microvascular endothelial cells transfected with p47phox S303/304A mutated 
plasmid. 
In conclusion, the results from my Ph.D project have shown that activation of endothelial 
NADPH oxidase requires phosphorylation of p47phox• Several p47phox serines, including 
S303/304, S315, S328, S345, S370 and S379, are involved in acute TNFa-induced p47phox 
phosphorylation in Endothelial ROS production. However, their different effects on TNFa-
induced ERK1I2 phosphorylation indicate a more complicated molecular mechanism of 
phosphorylation among these individual serines. 
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6.2 Future Work 
My study has shown that endothelial p47Phox undergoes multiple serine phosphorylations in 
response to acute TNFa stimulation, and individual serine phosphorylation may have 
different regulatory roles in regulation of NADPH oxidase activation and downstream 
signalling. My future investigation may firstly target on p47phox S303/304 and S379, both of 
which are important for NADPH oxidase activation, but exhibit a different effect on MAPK 
signalling. Based on current literatures, we speculate that phosphorylation at S379 is 
essential for p4 7phox membrane translocation, and phosphorylation at S303/304 may occur 
afterwards to further optimise p47phox to form an activated structure. In the mean while, 
p47phOX may have another role to trans locate TRAF4 to the membrane, leading to MAPK 
activation. To understand the regulatory mechnisms of indivual p47phox serine 
phosphorylation in the activation of endothelial NADPH oxidase during TNFa stimulation, 
the future work is listed below: 
1) To examine and confirm the roles of other serines, such as p47phox S379, in acute 
TNFa-MAPK signalling. 
2) To explore the relationship between p47phox serine phosphorylation and p47phox 
membrane translocation. 
3) To investigate the effect of p47phox serine phosphorylation on p47phox_TRAF4 binding 
during acute TNFa stimulation. 
4) To investigate the role ofp47phox serine phoshorylation in chronic TNFa stimulation. 
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